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Abstract
Comparing Performance of Gene Set Test Methods Using Biologically Relevant Simulated
Data
by
Richard M. Lambert, Master of Science
Utah State University, 2018

Major Professor: John Stevens, Ph.D.
Department: Mathematics and Statistics
Determining differential gene expression in two or more sample groups is of great
biomedical interest in understanding the genetic causes of diseases and health conditions
and evaluating efficacy of genetic treatments. Gene set testing is a relatively new method of
testing for differential expression between sample groups by creating groups of functionally
related genes called gene sets. In this research, we evaluated and compared the statistical
power and false discovery rate of the following gene set test methods: mvGST, ROAST,
CAMERA, ROMER, GlobalTest, GSA, PAGE, SAFE, sigPathway, and GSEAlm.
We developed a simulation framework to generate datasets that are both biologically
relevant and representative of actual gene expression data. We identified several biological
parameters of interest and determined realistic values for each of them by either sampling
real gene expression data sets or literature review. We then identified 5 interesting parameter pairings and tested each combination of parameter values with either 50 or 100
simulated data sets to determine how power and FDR vary as a function of each parameter
as well as identify possible interactions between parameters.
(118 pages)
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Public Abstract
Comparing Performance of Gene Set Test Methods Using Biologically Relevant Simulated
Data
Richard M. Lambert

Today we know that there are many genetically driven diseases and health conditions.
These problems often manifest only when a set of genes are either active or inactive. Recent
technology allows us to measure the activity level of genes in cells, which we call gene
expression. It is of great interest to society to be able to statistically compare the gene
expression of a large number of genes between two or more groups. For example, we may
want to compare the gene expression of a group of cancer patients with a group of non-cancer
patients to better understand the genetic causes of that particular cancer. Understanding
these genetic causes could potentially lead to improved treatment options.
Initially, gene expression was tested on a per gene level for statistical difference. In more
recent years, it has been determined that grouping genes together by biological processes
into gene sets and comparing groups at the gene set level probably makes more sense
biologically. A number of gene set test methods have since been developed. It is critically
important that we know if these gene set test methods are accurate.
In this research, we compare the accuracy of a group of popular gene set test methods
across a range of biologically realistic scenarios. In order to measure accuracy, we need to
know whether each gene set is differentially expressed or not. Since this is not possible in
real gene expression data, we use simulated data. We develop a simulation framework that
generates gene expression data that is representative of actual gene expression data and
use it to test each gene set method over a range of biologically relevant scenarios. We then
compare the power and false discovery rate of each method across these scenarios.
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Chapter 1
Introduction
In simple terms, the central dogma of molecular biology states that DNA in cells gets
transcribed into RNA which gets translated into proteins [1, 2] which regulate or govern
biological functions. An individual gene is a subsection of the entire DNA sequence that
represents a certain biological function. For example, one gene may be involved in cell
differentiation and another in apoptosis. At different stages of a cell’s development and life
cycle, the activity level of each gene, or gene expression, is controlled by a process called
gene regulation.
Microarrays can measure the gene expression levels of a large number of genes simultaneously. By comparing gene expression levels of normal subjects with those of subjects
with some disease or condition, we can try to understand genetic causes of diseases and
health conditions. Furthermore, potential treatments can similarly be tested at the gene
expression level to see if they are addressing the underlying genetic causes. Therefore, there
is great value in interpreting gene expression data.
Gene expression datasets often have thousands or tens of thousands of variables (p
genes) and only a few observations (n subjects). Traditional statistical methods often fail
on high-dimensional data (when p >> n). To resolve this issue, a new type of method
called gene set testing was developed. The gene set test idea more or less originated with
the Gene Set Enrichment Analysis method, commonly referred to as GSEA [3]. Since then,
many other gene set test methods have been developed.
The basic idea of gene set testing is that genes with similar function are grouped
together into clusters called gene sets and a statistical test is performed at the gene set
level instead of the gene level. This greatly reduces the dimensionality of the data for the
statistical test being used. In practice, gene sets are usually created based on biological
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processes, as annotated in a public gene database such as the Gene Ontology (GO) [4, 5] or
KEGG [6]. In a sense, each gene set is a proxy for a particular biological process.
Once the gene sets have been created, a statistical test is performed at the gene set level
instead of the individual gene level. For any particular gene set, if there is a statistically
significant difference in gene expression levels between any two test groups, we say that
there is differential expression (DE) between those groups for that gene set. A significant
result also implies that the activity level of the biological process represented by the gene
set is different between subject groups.
In addition to GSEA, many other gene set methods have been developed such as
GSEAlm (GSEA linear model) [7], ROAST [8], CAMERA [9], ROMER [10] GlobalTest [11],
mvGST [12], PANTHER [13], sigPathway [14], SAFE [15], PAGE [16], GSA [17], SAM-GS
[18], and Ingenuity Pathway Analysis [19]. The goal of each of these gene set test methods
is the same, to detect differential expression of gene sets, but the statistical methodologies
of each method are quite different. Therefore, it is of interest to see which methods perform
the best in detecting true positives while avoiding false positives for various biologically
realistic and relevant scenarios.
The purpose of this research was to investigate and explore the statistical performance
of a number of gene set test methods by simulating gene expression data where we controlled
which gene sets were differentially expressed (DE) and which were just noise. A number of
test scenarios were devised that represented realistic gene expression data and experiment
designs. For each scenario, we generated 100 data sets and tested each of them with each
gene set method. With each method, we recorded the power (rate at which the generated
DE gene sets were actually found to be significant) and the false discovery rate (FDR,
proportion of gene sets found to be significant that were actually non-DE).
In chapter 2, we review previous work that involved comparing gene set test methods.
In particular, we will focus on those that used simulated data to compare methods. With
the exception of Fridley et al. [20], there has been little comparable work in doing large
scale simulation studies across gene set methods.
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Another aspect that is lacking in the current gene set simulation literature is whether
the test scenarios are biologically meaningful or whether the generated data is biologically
realistic. If the test scenarios are unrealistic, the theoretical power of a method is of little
value to the scientists who might actually use the method. In chapter 3, we establish biological relevance of the test scenarios we designed and the realism of the data we generated.
Chapter 4 introduces and briefly describes the 18 gene set test methods (10 core methods and 8 variations) we tested in this research. It includes the type and technique of each
method which will be used in the final analysis.
To perform this research, a test framework was developed in the R programming language [21] to simulate the datasets of gene expression data, run each data set through each
of the gene set test methods, record the power and FDR of each method, and generate
interesting plots. Chapter 5 describes this R framework in great detail. It also provides the
details of the specific scenarios that were tested.
The simulation results for each of the test scenarios are then presented and discussed
in detail in chapter 6. Each section covers a different pairing of biological parameters and
includes a description of the scenario, lattice plots of power and FDR, and an analysis of
the results.
Finally, chapter 7 concludes by summarizing the results and providing direction for
future work.
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Chapter 2
Related Work
The literature review here is focused on other research done comparing the statistical
performance of gene set methods. In particular, we focus on comparisons that involve using
simulated gene expression data to test at least and compare at least two gene set test
methods and on comparison tests that compare a large number of statistical methods.
One of the most comprehensive simulation tests was done by Wu et al. [8] comparing
the statistical performance of their method, ROAST, with the GSEAlm method (a linear
model version of GSEA). In their research, they simulated datasets for 10,000 genes. Each
gene had its own variance which was sampled from the inverse-χ2 distribution

1
σ2

∼

1 2
χ
s20 d0

where d0 = 4 and s0 = 0.25. The genes were divided into gene sets in two ways, 250 gene
sets of size 40 and 10 gene sets of size 1000. A full set of test scenarios were run for each
setup. Although not explicitly stated, we presume that those gene set sizes represent typical
gene sets of interest in real data. For each of these two gene set setups, 10 test scenarios
were tested. Each test scenario was a certain combination of the parameters: proportion of
genes up-regulated in the set (0, 0.2, 0.25, 0.5, 1), proportion of genes down-regulated in
the set (0, 0.2, 0.5), inter-gene correlation (0 or 0.1), and the log-fold change to be used for
the DE genes (0.1, 0.2, 0.3, 0.4). The log-fold change for each scenario was chosen to meet
a theoretical power given the test setup as opposed to a biologically meaningful value. The
first eight scenarios were designed to test statistical power and were run with 1000 simulated
data sets. In these scenarios only the first gene set contained DE genes according to the
test scenario parameters. The last two scenarios were designed to test type I error rate and
were run on 3000 simulated data sets. In these scenarios, no genes were generated with DE.
It is again presumed, but not explicitly stated, that the 10 test scenarios represent realistic
gene expression data. A final note of interest is they generated data for three groups, but
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only tested two groups. For one complete set of simulations, they used n1 = n2 = 3 and
n3 = 20 samples and for another set, they used n1 = n2 = 5 and n3 = 20 samples. The
data for the third group were passed into the method, but were not included in the test
for significance. In this way, ROAST likely outperformed GSEAlm because it was able to
“make use of residual degrees of freedom from the 20 arrays in the third group that is not
involved in the hypothesis test” [8].
Wu and Smyth [9] conducted a similar set of simulations comparing their method,
CAMERA, with the methods geneSetTest, PAGE, and sigPathway. As in the ROAST test,
they again used 10,000 genes and generated the data according to an inverse-χ2 distribution.
In this case, the genewise variances were sampled from the distribution: σ 2 ∼

s20 d0
χ2d

with

0

d0 = 4 and s0 = 0.25. This is the reciprocal of the formula used in the ROAST study, with
an added coefficient in the numerator, d0 . The authors state here that this generates “a
distribution typical of microarray experiments” [9]. There were four test scenarios described:
100% genes DE, intergroup gene correlation = 0, log-fold change = 0.05; 100% genes DE,
intergroup gene correlation = 0.05, log-fold change = 0.1; 25% genes DE, intergroup gene
correlation = 0, log-fold change = 0.2; and 25% genes DE, intergroup gene correlation =
0.05, log-fold change = 0.25. Each scenario was run with 1000 simulated data sets. Other
than the genewise variance used to generate the expression data, no biological justification
was given for any of the choices of parameter values.
Efron and Tibshriani [17] performed a simulation study comparing the GSA method
with GSEA. They ran their simulations with 1000 total genes split into 50 gene sets of size
20 and n1 = n2 = 50 samples per group. The data for all genes were generated from the
normal distribution: N (0, 1), then a DE effect was added to certain genes in just the first
gene set of group 2 (called the DE set) based on the test scenario. The 5 test scenarios
were: add 0.2 to all 20 genes in the DE set; add 0.3 to the first 15 genes in the DE set; add
0.4 to the first 10 genes in the DE set; add 0.6 to the first 5 genes in the DE set; add 0.4
to the first 10 genes in the DE set and subtract 0.4 from the last 10 genes in the DE set.
No reasoning was given for the choices of sample size, gene set size, or log-fold difference.
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Each of the 5 test scenarios were performed with 20 simulated data sets.
Fridley et al. [20] performed a large-scale simulation study that was the most similar
to this research of all the surveyed literature. In their study, they compared a handful
of standard statistical methods such as the Kolmogorov-Smirnov test, Fisher’s method,
Stouffer’s method, Tail strength, Global Model, and Principal Component Analysis. They
tested over 2000 different scenarios. The parameters for their scenarios were: number of
genes per gene set (10, 50, 100, 500), number of associated genes (varies based on number
of genes in set), the effect sizes for those associations (small = 1, medium = 2, large = 3),
inter-gene correlation (0, 0.1, 0.3), standard deviation of gene expression data (1, 3, 6), and
sample size (20, 100, 50). For each scenario, 1000 datasets were generated and tested. Gene
expression values were generated from M V N (0, Σ) where Σ was the covariance matrix
for the test scenario. For scenarios without gene correlations, it was a diagonal matrix
containing the variance of each gene. For scenarios with gene correlation, it is a structure
that contains 1 for the variance on the diagonal and the correlation value determining
the off-diagonal. For the differentially expressed genes, they were sampled from a normal
distribution N (µ, σ) where µ = 0, 1, 2, 3 (for no effect, small effect, medium effect, or large
effect). The total number of genes used for the test scenarios was not mentioned. Again,
no biological justification was given for any of the choices of parameter values.
Song and Black [22] did a simulation study comparing GSEA, GSEAlm, SAFE, GlobalTest, sigPathway, and PCOT2 (Principal Coordinates with Hotelling’s T 2 ). In this simulation study, they simulated data for 400 total genes split equally into 20 gene sets with
20 genes per gene set. There were 2 groups with 20 samples in each group. There were 4
basic scenarios which were performed under various values of inter-gene correlation and the
actual mean difference between groups: both groups inactive with no significant difference,
group 1 genes active and group 2 genes inactive with a significant difference, both groups
active with no significant difference, and both groups active with a significant difference.
They first ran each basic scenario holding the mean difference constant at 0.5 or 1 over a
range of inter-gene correlation values ranging from 0 to 0.5 in increments of 0.05. Then,
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they ran the basic scenarios again, this time holding the correlation constant at either 0.1
or 0.25 over a range of mean differences from 0.5 to 5 in increments of 0.5. For each test
run, 100 data sets were simulated. They then used two real data sets to obtain realistic
values of p (total genes), and estimates for µ (mean difference) and Σ (covariance matrix)
and performed the tests again.
Goeman and Bühlmann [23] conducted a simulation study to show the relationship
between the inter-gene correlation and type I error rate. They generated 5000 data sets
for each value of inter-gene correlation from 0 to 1 in steps of 0.1. The data sets each had
10,000 genes which were divided into 100 gene sets with 100 genes in each. There were
2 groups with 10 samples in each group. The data were generated from a multivariate
normal distribution with mean of 0 and variance of 1. They showed that as the inter-gene
correlation increases, the number of false positives increases.
Liu et al. [24] performed a simulation study to compare 3 gene set test methods (Global
Test, ANCOVA Global Test, and SAM-GS). In their study, they simulated data for a
single gene set containing 100 genes for 2 groups of samples and tested both power and
size for a combination of 2 sample sizes (10 per group and 25 per group) and 3 inter-gene
correlation values (0, 0.5, and 0.9). Gene expression data was generated from a multivariate
distribution. For the size (type I error rate) tests, none of the genes were differentially
expressed. For the power tests, 40 of the 100 genes were differentially expressed.
A number of other papers were found that compared performance of gene set test
methods but either did not use simulated data sets or were more limited in scope. Dinu et
al. [25] compared 6 gene set test methods (GSEA, SAM-GS, Global Test, ANCOVA Global
Test, sigPathway, and Tomfohr) on the NCI-60 data set. Tarca, Bhatti, and Romero [26]
performed a comparison test of sixteen methods under relaxed assumptions while using 42
real datasets. No simulations were done in either study. Bayerlov et al. [27] compared
performance of SPIA, CePa and Pathnet using simulated data sets. These methods are
actually considered pathway topology-based enrichment methods, which are similar to gene
set test methods but use additional information about the structure or topology of the genes.
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Evangelou et al. [28] proposed that some standard association tests could be adapted to
test for gene set enrichment. They compared their results only to GSEA and found the
adapted association tests generally outperformed GSEA.
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Chapter 3
Biological Relevance
3.1

Overview
The primary objective of this research was to compare statistical performance (power

and false discovery rate) of gene set testing methods for various biologically realistic and
relevant scenarios. Publicly available gene expression data sets from experiments are both
realistic and relevant, but pose some interesting challenges. Since it is not known a priori
which gene sets are differentially expressed, it is not possible to determine which significant
findings are true positives and which are false positives. It was also not feasible to find a
large sample of data sets for each of our desired test scenarios. We therefore used simulated
data for this research.
To ensure that the simulated data sets were biologically realistic and relevant, we
identified a number of biological parameters of interest that would be used in the simulation
framework. For each one, we performed an analysis to determine the range of values that
would capture a majority of real-life scenarios. In this way, the simulation results show how
each of the gene set test methods perform over a variety of realistic scenarios.

3.2

Parameters of Interest
The parameters of interest that we chose to explore and model in the simulations were:

the per gene expression variance σ 2 , the total number of genes p, the number of samples per
group in experiments n, the number of genes in each gene set m, the fold-change difference
in expression between groups that is actually biologically meaningful µd , the proportion of
genes in the gene set that are differentially expressed πd , and the inter-gene correlation r.
Other parameters, such as the degree of gene set overlap, were considered but ultimately
left out of the scope of this research.
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3.2.1

Sample Size

For the number of replicate samples per group, n, in typical experiments, we randomly
selected 60 gene expression data sets from the Gene Expression Omnibus (GEO) [29, 30].
We excluded experiments which involved repeat measurements on the same subjects as well
as a few experiments which had very unbalanced designs. There was no restriction on the
study year, but slightly more weight in the randomization was given to studies from 2013
and newer. For each study, the average number of samples per groups was recorded and
summarized.
As seen in Fig. 3.1, the distribution is right skewed with most experiments using 10
or less samples per group. 88% of the experiments used 6 or less samples per group and
95% of the experiments used 10 or less samples per group. For the number of samples per
group of the 60 sampled experiments, the summary statistics are shown in Table 3.1 Further
non-random investigation of GEO datasets revealed that nearly all experiments used 50 or
fewer samples per group. For the purposes of our simulations, we decided to use the values
n ∈ {2, 4, 6, 8, 10, 25, 50}.
Table 3.1: Summary Statistics of GEO Experiment Sample Sizes
Statistic
Value
min
2
1st quartile
3
median
3
3rd quartile
5
max
23
mean
4.7
standard deviation
4.07
experiments with ≤ 6 samples 88.33%
experiments with ≤ 10 samples
95%

3.2.2

Gene Set Size

To estimate the distribution of gene set size parameter, m, we wrote an R [21] script
to traverse the human genome as annotated in the R library org.Hs.eg.db [31] and cross
reference each gene set with the Gene Ontology library GO.db [32] and AnnotationDbi [33]
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Fig. 3.1: Distribution of the number of samples per group in 60 randomly selected GEO
data sets
to determine which ones were annotated as biological processes. For each gene set that was
annotated as a biological process, the size of the gene set was recorded. There were 22302
gene sets in org.Hs.eg.db, 15795 of which where tagged as biological processes in GO.db.
The distribution of gene set sizes for every biological process in the human genome was
extremely right-skewed with a median of 7 and a mean of 130.8807. Full summary statistics
can be seen in Table 3.2. We note that the hierarchical nature of the gene sets in the human
Table 3.2: Summary Statistics of Gene Set Sizes from the Human Genome
Statistic
Value
min
1
1st quartile
2
median
7
3rd quartile
31
max
38038
mean
130.8807
standard deviation
903.7878
gene sets with ≤ 50 genes
80.78%
gene sets with ≤ 100 genes 87.24%
gene sets with ≤ 150 genes 90.42%
genome library (org.Hs.eg.db) creates some very large gene sets that are not biologically
meaningful. For instance, the root biological process GO:0008150 contains every single
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gene involved in any biological process. One of its children, GO:0048518, contains any gene
involved in positive regulation of biological process [4]. In the context of gene set testing,
these giant generic container gene sets have no meaning. As seen in Table 3.2 and Fig. 3.2,
most gene sets contain 100 or fewer genes.
Given the results of this analysis, we would have ideally used a range of gene set sizes
such as from 10 to 100 in increments of 10. After exploring each of the parameters of
interest, we devised a complete list of desired test scenarios. Due to the large number of
test scenarios and computation time that would be needed, it was impractical to run them
all. As a result, we had to scale back some of the less interesting parameters, such as gene
set size. In particular, we decided to use m = 40 genes per gene set for all test scenarios.

Fig. 3.2: Cumulative density plot of the gene set size from every biological process gene set
in the human genome.
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3.2.3

Genewise Expression Variance

Prior work has been done in exploring the expression distribution of each gene. Lönnstedt
and Speed [34] and Wright and Simon [35] both proposed that the variance for each gene
follows an inverse gamma distribution common to all genes. Smyth [36] extended this idea
and suggested that genewise variances follow an inverse-χ2 distribution

1
σ2

∼

1
χ2 .
d0 s20 d0

Fur-

ther work by Wu et al. [8] and Wu and Smyth [9] also used the same inverse-χ2 distribution
and suggested that using the values d0 = 4, s0 = 0.25 will generate realistic gene expression
data sets.

3.2.4

Biologically Relevant Differential Expression

There is an important difference between statistical significance and biological importance. A result is statistically significant when the observed difference was not likely due
to chance. A result is biologically meaningful when the observed difference (effect size) is
large enough to be important. It is common for biological experiments to have statistically
significant results that are not biologically meaningful and vice versa [37]. Therefore, we are
primarily interested in the statistical power of the gene set test methods in detecting biologically meaningful differences. To determine a range of biologically meaningful differential
expression values for our DE fold-change parameter, µd , we turn to the literature.
Yang et al. [38] suggest that fold-change values as low as 1.3 may be biologically meaningful. Huggins et al. [39] used a fold-change cutoff of 1.3 to define meaningful differential
expression. Peart et al. [40] and Raouf et al. [41] both considered fold-change differences of
1.5 and above to be biologically meaningful. McCarthy and Smyth [42] used a fold-change
of 1.5 and suggested that fold-change differences of 1.1 or smaller are definitely not biologically meaningful. Combining all of these results suggests that fold-change differences less
than 1.1 are definitely not meaningful, 1.1 to 1.3 are probably not meaningful, 1.3 to 1.5
might be meaningful, and greater than 1.5 are most likely meaningful. We therefore used
fold-change values µd ∈ {1.3, 1.5, 1.7}.
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3.2.5

Inter-Gene Correlation

Gatti et al. [43] performed a meta-analysis on a total of 202 datasets (8,656 arrays)
from the Gene Expression Omnibus [29, 30] and concluded that inter-gene correlation is
widespread in gene expression data and that inter-gene correlation inflates the rate of false
discoveries. From their scatterplots, it appears that most of the inter-gene correlations were
between 0 and 0.2 and almost all of them were between 0 and 0.3.
Wu and Smyth [9] also showed that inter-gene correlation increases the type I error
rate of gene set test methods. They computed inter-gene correlations for all gene sets with
5 or more genes in the C2 collection of the Molecular Signatures Database Version 3.0
(MSigDB) [3,44]. The mean inter-gene correlation was 0.0026 and ranged up to 0.71. From
their boxplot of correlations, it appears that there was 1 negative correlation, that the IQR
of correlations was between 0 and approximately 0.15 and that almost all of the correlations
were between 0 and 0.4.
For our simulations, we used the values r ∈ {0, 0.1, 0.2, 0.3} for inter-gene correlation.

3.2.6

Proportion of Differentially Expressed Genes

Finally, the proportion of genes in the gene set that are differentially expressed can
realistically be anything between 0 and 1. We used πd ∈ {0, 0.25, 0.5, 0.75, 1} to cover the
full range of possible values.

3.3

Summary
We have attempted to identify important biological parameters and estimate represen-

tative ranges of values to use in our simulations. All parameters of interest are summarized
here in Table 3.3. The actual test scenarios that were derived from this list and which were
used in the simulations is described in the following chapter.
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Table 3.3: Summary of Parameters of Interest
Parameter
Values
Justification
1
1
2
genewise expression variance
∼ d s 2 χd 0
multiple sources [8, 9, 36]
σ2
σ2
total number of genes
p
gene set size
m
samples per group
n
biologically relevant fold-change
µd
proportion of DE genes
πd
inter-gene correlation
r

0 0

d0 = 4, s0 = 0.25
2,000, 4,000, 6,000
8,000, 10,000
40
2, 4, 6, 8, 10, 25, 50

1,000 previously used [17]
10,000 previously used [8, 9, 23]
analysis of human genome [31–33]

1.3, 1.5, 1.7

sample of 60 experiments
from GEO [29, 30]
multiple sources [38–42]

0, 0.25, 0.5, 0.75, 1

cover complete possible range

0, 0.1, 0.2, 0.3

Gatti et al. [43]
Wu and Smyth [9]
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Chapter 4
Gene Set Test Methods
4.1

Overview
We tested a total of 19 gene set methods: mvGST, mvGST: Hartung, GlobalTest,

ROAST: mean, ROAST: msq, ROAST: floormean, CAMERA, ROMER: mean, ROMER:
floormean, GSEAlmperm, GSA: maxmean, GSA: mean, GSA: absolute mean, sigPathway:
NTk, sigPathway: NEk, SAFE: permutation, SAFE: bootstrap.t, SAFE: bootstrap.q, and
PAGE (PGSEA). Rather than describe them individually, this chapter summarizes the
major types of approaches, with references appearing in a concluding table.
PANTHER [13] is a popular classification system that can also do gene set testing.
Ingenuity Pathway Analysis [19] is a commercial product that can do gene set testing.
Both were excluded due to lack of R support. We also excluded geneSetTest [45] because
it has been been superseded by CAMERA as noted by its authors [9].

4.2

Hypothesis Type
As originally stated by Goeman and Bühlmann [23], there are two main types of gene

set tests, competitive and self-contained. In competitive gene set tests, each gene set G is
compared to the gene set consisting of all other genes not in G - its complement, Gc . The
null hypothesis for the competitive test is that the genes in G are differentially expressed as
often as the genes in Gc . Self-contained gene set tests compare the genes in a set to a fixed
standard and do not use information from genes outside of the set. The null hypothesis for
the self-contained is that no genes in G are differentially expressed.
In general, it is thought that self-contained tests have more power than competitive
tests but can be too powerful [23] and that competitive tests may be prone to serious errors
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in both significance and interpretation [24]. Self-contained tests also have the ability to test
a gene set consisting of all genes, whereas competitive tests cannot.
The competitive tests we tested were: CAMERA, GSA: maxmean, GSA: mean, GSA:
absolute mean, PAGE (PGSEA), ROMER: mean, ROMER: floormean, SAFE: permutation,
SAFE: bootstrap.t, SAFE: bootstrap.q, and sigPathway: NTk. The self-contained tests
were: sigPathway: NEk, mvGST, ROAST: mean, ROAST: msq, ROAST: floormean, and
GlobalTest, and GSEAlmperm.

4.3

P-value Technique
The technique used to generate the gene set p-values also varies across methods. Some

of them calculate the p-value by combining the p-values from each of the genes in the gene
set, others by permuting over the samples, others by permuting over the genes, and others
by rotating residuals.
A few of the methods use fairly standard statistical methodology. The CAMERA
method uses a two-sample t-test where the test statistic T has been adjusted by the Variance
Inflation Factor (VIF) to account for inter-gene correlation [9]. The PGSEA method is a
parametric method that assumes a normal distribution and uses a one-sample z-test to
compare each gene set mean Sm to the population mean µ and standard deviation σ from
the entire data set [16]. The mvGST method uses either Stouffer’s Method or Hartung’s
Method to combine p-values from individual genes into a p-value for each gene set [12].
The GlobalTest assumes a normal distribution or a χ2 distribution for small sample size by
default but can also estimate the distribution by permutations [11].
A number of methods use resampling techniques to generate the unknown distribution
of test statistics, then check each gene set test statistic against the distribution to generate
their p-values. These can be classified further by the resampling technique. Some methods permute samples, others permute genes, others permute sample and genes, and some
use bootstrapping techniques. The methods that permute over samples are: sigPathway:
NEk [14], GSEAlm [7]. The only method tested here that permutes over genes is sigPathway: NTk [14]. Two methods permute over both genes and samples. The SAFE method [15]
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permutes over genes to find the test statistic and then permutes over samples to calculate
the p-value. The GSA methods also permute over genes and samples to generate the test
statistic distribution, a process they call restandardization. The statistic distribution is
then used to generate p-values for each gene set [17]. Finally, two of the SAFE methods use
bootstrap sampling in their tests [46]. They generate bootstrap confidence intervals and
then test each gene set statistic against the lower bound of the confidence interval. One of
those methods (bootstrap.q) uses the sample α-quantile [47] for the lower bound while the
other (bootstrap.t) generates the lower bound from the t-distribution.
Finally, the ROAST methods and the ROMER methods use rotation tests to generate
the gene set p-values. First, they project the data onto an orthogonalized residual space.
Then, they perform many random rotations of the residuals and calculate the test statistic at
each rotation. The set of test statistics generated this way is used to estimate the unknown
distribution (sometimes called the null distribution) of test statistics. The observed test
statistic for each gene set is compared against the null distribution to calculate its p-value. [8,
45].

4.4

Summary
The gene set method hypothesis types and p-value techniques discussed here will be

used again during the analysis to assess which type of hypothesis test or p-value technique
has any advantage over the others given each set of circumstances. See Table 4.1 for
a summary of gene set methods along with their hypothesis type and p-value calculation
technique. In total, we tested 19 methods which can be divided into 11 competitive methods
and 8 self-contained methods or as 3 parametric methods, 5 rotation methods, 9 resampling
methods (7 permutation and 2 bootstrap), and 2 p-value combination methods.
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Gene Set Test Method
CAMERA
GSA: maxmean
GSA: mean
GSA: absmean
PGSEA

Table 4.1: Gene Set Methods
Hypothesis Type
P-value Technique
competitive
parametric
two-sample t-test [9]
competitive
resampling
permutation of genes and samples [17]
competitive

ROMER: mean
ROMER: floormean
SAFE: permutation

competitive

SAFE: bootstrap.t
SAFE: bootstrap.q
sigPathway: NTk

competitive

sigPathway: NEk

self-contained

mvGST

self-contained

mvGST: Hartung

self-contained

ROAST: mean
ROAST: msq
ROAST: floormean
GlobalTest

self-contained

GSEAlmperm

self-contained

competitive

competitive

self-contained

parametric
one-sample z-test [16]
rotation of residuals [45]
resampling
permutation of genes and samples [15]
resampling
bootstrap [46]
resampling
permutation of genes [14]
resampling
permutation of samples [14]
combine p-values
Stouffer’s Method [12, 48]
combine p-values
Hartung’s Adjustment [12, 49]
rotation of residuals [8]

parametric
logistic regression [11]
resampling
permutation of samples [7]
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Chapter 5
Simulation Framework
5.1

Overview
The simulation framework was written in the R programming language [21]. All sim-

ulation tests described in this work were run on the Ember cluster at the Center for High
Performance Computing at the University of Utah (CHPC). We will describe the test scenarios, define power and false discovery rate (FDR), and then discuss the simulation framework
in detail. We will then comment on some tuning parameters that were used for some of
the methods, describe the computing environment, and conclude with a brief comment on
performance.

5.2

Test Scenarios
The test scenarios are based on the previously defined parameters of interest and their

typical values (Table 3.3). In addition to estimating the power and false discovery rate
of the gene set test methods as a given parameter varied, we wanted to explore possible

interactions between parameters. Given the 6 parameters we identified, there were 62 = 15
possible pairings. For each pairing, we permuted over the full combination of parameter
values and tested each combination with 100 unique simulated data sets.
In order to limit the total computation time and the scope of this research, we focused
our efforts on the 5 most interesting pairings as follows: number of genes with sample size,
sample size with fold-change, sample size with proportion DE, sample size with correlation,
and proportion DE with correlation. For each pairing, we tested all combinations of parameters and estimated power and false discovery rate for each gene set test method. In
total, there were 128 test scenarios across the parameter pairings. After accounting for 28
overlapping scenarios, 100 unique test scenarios were actually tested. For scenarios with 10
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or fewer samples per group, 100 unique gene expression data sets were simulated and tested
with all gene set test methods. For scenarios with more than 10 samples per group, 50 data
sets were simulated. The test scenarios are summarized in Table 5.1.

Number of Genes
p
2000, 4000, 6000,
8000, 10000
4000
4000
4000
4000

5.3

Table 5.1: Test Scenario Parameter Pairings
Gene Set Size Sample Size Fold-Change Proportion DE
m
n
µd
πd
40
2, 4, 6, 8,
1.5
1
10, 25, 50
40
2, 4, 6, 8
1.3, 1.5, 1.7
0.5
10, 25, 50
40
2, 4, 6, 8
1.5
0.25, 0.5, 0.75, 1
10, 25, 50
40
2, 4, 6, 8
1.5
1
10, 25, 50
40
6
1.5
0.25, 0.5, 0.75 1

Correlation
r
0
0
0
0, 0.1, 0.2, 0.3
0, 0.1, 0.2, 0.3

Significance
In gene set tests, a test of significance is performed on each gene set. The null hypothesis

H0 for a particular gene set states that there is no difference in gene expression between
sample groups. Since there are many gene sets all being tested with the same H0 , the
results need to be adjusted for multiple hypothesis testing in order to control the FDR.
If the FDR adjusted p-value for a given gene set pa ≤ α, there is a significant difference
of gene expression between groups in that gene set and we say the genes are differentially
expressed between groups. A significant result is often referred to as a discovery.

5.4

Multiple Hypothesis Correction
Some of the gene set test methods used here have an FDR adjustment built in and

some of the methods do not. By default, mvGST uses a Benjamini-Yekutieli correction
(BY) [50] while ROAST, CAMERA, SAFE and PGSEA all use a Benjamini-Hochberg
correction (BH) [51] by default. The sigPathway methods use their own implementation
of q-values for multiple hypothesis testing [14]. The GlobalTest, ROMER, GSEAlm, and
GSA methods did not have an FDR adjusted p-value from the function API.
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When an FDR adjusted p-value was available directly from a method, we used the
default adjustment method built-in to the method function call, then used the p-value
returned from the method as our FDR adjusted p-value, pa . For methods that only returned
raw p-values, we manually adjusted the vector of raw p-values using the p.adjust method
built in to R [21] with the Benjamini-Hochberg correction (BH) [51], then used the adjusted
p-value from the first gene set as our pa . A summary of FDR corrections used by each
method, including whether it was done manually, is show in Table 5.2.
Table 5.2: Multiple Hypothesis Adjustment Methods Used for Each Method
Gene Set Test Method FDR Method Manually Adjusted?
mvGST
BY
N
ROAST: mean
BH
N
ROAST: msq
BH
N
ROAST: floormean
BH
N
CAMERA
BH
N
SAFE: permutation
BH
N
SAFE: bootstrap.t
BH
N
SAFE: bootstrap.q
BH
N
PGSEA
BH
N
sigPathway: NTk
q-value
N
sigPathway: NEk
q-value
N
GlobalTest
BH
Y
ROMER: mean
BH
Y
ROMER: floormean
BH
Y
GSEAlmperm
BH
Y
GSA: maxmean
BH
Y
GSA: mean
BH
Y
GSA: absmean
BH
Y

5.5

Power
We define the power of a given method as P {reject H0 | H0 is f alse}. We stipulate

that H0 should be false whenever there is a biologically relevant difference in gene expression
between groups. The power of each method, therefore, is the proportion of biologically
relevant differences that it detects as significant discoveries.
For each simulated data set, a proportion of the genes in the first gene set were generated with differentially expressed values for all of the samples in the second group. The
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proportion of genes and fold-change for the differentially expressed gene set varied according
to the test scenario being run. Any remaining genes in the first gene set and all genes for
all other gene sets were generated from a MVN distribution as described in Section 5.7.2
such that none of the other gene sets should be differentially expressed between groups.
The power, P , for each method at a given test scenario is estimated as P =

ns
s

where

ns is the number of significant findings for gene set 1 out of the s simulated data sets.
For test scenarios with 10 or fewer samples, s = 100, and for test scenarios with 25 or 50
samples, s = 50. These values were chosen to balance the trade-off between accuracy and
computation time.

5.6

False Discovery Rate
We define the false discovery rate (FDR) for a method as Q =

V
R

where V is the

number of false positives and R is the total number of discoveries. In other words, it is the
proportion of significant results that are incorrect.
The false discovery rate for a single data set in a single test run, i, was estimated as
Qi =

Vi
Ri

where Vi is the number of false positives (significant findings other than the first

gene set) and Ri is the total number of significant findings for all gene sets. The false
discovery for each gene set test method at a given test scenario, Q, is then the average false
s
P
discovery rate across all s test runs, or Q = 1s
Qi .
i=1

5.7

Framework Components
The main simulation framework (see simulation.R in Appendix B) is an R script with

4 main steps: Initial Setup, Data Generation, Gene Set Tests, and Summarize Results. For
each test scenario, the Initial Setup is performed once, the Data Generation and Gene Set
Tests are performed s times in a loop, and the Final Summary is performed once. For each
scenario, the results for each gene set test method are saved to a results CSV file.
After running all pairwise scenarios for a parameter pairing, a fifth step is performed:
Final Analysis. This is a second R script (see analysis.R in Appendix B) which reads in
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a series of results CSV files, manipulates the data, and generates the relevant plots. Each
component will now be described in further detail.

5.7.1

Initial Setup

In the initial setup, the test parameters are read in from the command line, the gene
set structures for the various methods are created, and a starting time is recorded.

5.7.2

Data Generation

A matrix of gene expression data is generated based on the test scenario parameters.
Only the first gene set is generated as differentially expressed. As done in previous work [8,
9, 36], we first simulate genewise variance for each gene from the inverse-χ2 distribution:
1
σ2

∼

1
χ2
d0 s20 d0

using the values d0 = 4 and s0 = 0.25 For each gene set, a covariance matrix Σ

is constructed and gene expression data is simulated from a multivariate normal distribution
M V N (µ, Σ).
For test scenarios without inter-gene correlation (r = 0), Σ is a diagonal matrix of the
genewise variances, σ 2 . For test scenarios with inter-gene correlation (r 6= 0), a correlation
matrix, R, is constructed containing 1 along the diagonal and the inter-gene correlation
coefficient, r, everywhere else. A diagonal matrix, D, is also constructed from the genewise
standard deviations, σ. Then, the covariance matrix is the result of the matrix multiplication Σ = D × R × D. See Appendix A for a discussion about how the method used to
generate data with inter-gene correlation was validated with a feature of the CAMERA
method [45] that can estimate inter-gene correlation.
The value of µ depends on the values of the parameters m, µd , and πd for the test
scenario currently being run. For the first sample group, µ = 0 for all genes. For the second
sample group, the first πd × m genes in the first gene set have µ = log2 (µd ). For all other
genes in the second group, µ = 0.

5.7.3

Gene Set Tests

The simulated data set is then tested sequentially by each of the 19 gene set test
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methods. The data is massaged into the appropriate objects and formats required by the
method, the method is called, and p-values are obtained for all of the gene sets. If the
method returned raw p-values, they are manually converted to FDR adjusted gene set
p-values as discussed in Section 5.4.
The FDR adjusted p-values for each gene set are then tested against the predefined α
to determine significance. If an adjusted gene set p-value, pa ≤ α, the result is recorded as
significant for that gene set. Otherwise, it is recorded as not significant. The framework
allows any value of α to be specified, but the value α = 0.05 was used for all test scenarios.

5.7.4

Summarize Results

After all s data sets have been generated and tested, the power and FDR for each of
the 19 gene set test methods are summarized and saved to a uniquely named CSV file for
future processing by the Final Analysis step. The CSV file contains a row for each method
in the test and columns for the name of the test, the power, and the FDR.
The format of the filename is sim a b c d e f.csv where a is total number of genes, b is
the gene set size, c is the number of samples per group, d is the fold-change value, e is the
proportion of genes that are DE, and f is the inter-gene correlation coefficient. In this way,
we are able to run concurrent tests on the CHPC cluster and later combine the results for
analysis.
For each test completed, we also append a row to another CSV file, runlog.csv indicating
the test scenario parameters used, the start and end time, and the test duration. This file
was used to track CPU usage and calculate performance statistics.

5.7.5

Final Analysis

The test scenarios were designed to show both the impact of changing a parameter of
interest over its distribution of values and the interaction between pairs of parameters of
interest.
A series of test scenarios is the full combination of parameter values between a particular
pair of parameters of interest being tested. For example, with the pair number of genes
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(2000, 4000, 6000, 8000, 10000) and sample size (2, 4, 6, 8, 10), there are 5 × 5 = 25 total
test scenarios. These scenarios were run concurrently in batches on the University of Utah
CHCP cluster.
After a full series of related test scenarios was complete, the results are combined
and aggregated by a post-processing R script (analysis.R) to produce the desired summary
statistics and plots. The script loads every CSV in a directory and generates a new data
set with the gene set test methods as rows and columns for the significance rate, the total
number of genes, the gene set size, the sample size, the fold change, the proportion of genes
that were differentially expressed, and the inter-gene correlation. This data was used to
generate the lattice plots seen in the Simulation Results chapter.

5.8

Tuning Parameters

5.8.1

Number of Rotations

The 4 ROAST methods calculate the p-value by randomly rotating residuals in space [8].
The p-value is calculated as: (b + 1)/(nrot + 1) where b is the number of rotations giving
a more extreme statistic than that observed [52]. This smallest possible p-value is then
1/(nrot + 1). For ROAST to have power, it is vital to specify enough rotations so that it
is even theoretically possible to achieve a significant finding at the specified α. By default,
ROAST methods use 999 rotations. In testing, we found that with about ng = 125 gene
sets (5000 gene sets of 40 genes), using the default 999 rotations was insufficient to find
significance most of the time when considering the FDR corrected p-value. We empirically
determined that nrot = ng × 20 was sufficient to return fairly stable p-values over multiple
ROAST function calls with the same data set across multiple scenarios. The simulation
framework then uses ng × 20 rotations depending on the test scenario.
The ROMER methods also estimate the p-value by rotating orthogonalized residuals [10]. By default, ROMER methods use 9999 rotations. It was determined that using
9999 rotations was very CPU intensive and not practical given the total number of tests.
As with ROAST, we found that using ng × 20 rotations produced fairly stable p-values that
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allow ROMER to have adequate power across scenarios.

5.8.2

Number of Permutations

The sigPathway method and the GSEAlm method both use permutations to calculate
the p-value. The GSA method uses permutations to estimate the FDR rate. For each
of these methods, the number of permutations can be specified in the function call. By
default, sigPathway uses 1000 permutations, and GSA uses 200 permutations. GSEAlm
does not have a default number of permutations. In testing some possible choices for
this parameter in the simulation framework, it was empirically shown that using 1000
permutations/rotations for each of these methods was sufficient to produce fairly consistent
p-values across function calls with the same data set while keeping computation time fairly
reasonable. The simulation framework uses 1000 permutations for each of these methods
for all scenarios.

5.9

Test Environment
All simulations were performed on the Ember cluster at the CHPC. The cluster had

144 Dual Socket-Six Core Nodes (1728 total cores). Each core was a 2.8 GHz Intel Xeon
(Westmere X5660) processor with 2 Gbytes RAM per core. The cluster was running the
Linux CentOS release 7.4.1708 operating system.
The tests were run with R version 3.4.4 (2018-03-15) and a handful of R libraries which
were installed in the user subdirectory. The installed R libraries were primarily the various
gene set methods being tested. A summary of the R libraries is shown in Table 5.3.
Multiple test scenarios were run concurrently on different nodes in the cluster and the
results were later combined and analyzed as previously described. The SLURM scheduler
on the system controlled the queuing and scheduling of jobs.

5.10

Performance

An early version of the simulation framework did not scale well with the number of
genes. As the total number of genes p increased, the run time increased exponentially as
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R Library
mvnfast [53]
mvGST [54]
globaltest [55]
limma [45]

Version
0.2.5
1.14.0
5.32.0
3.34.9

GSEAlm [56]
GSA [57]
sigPathway [58]
safe [59]
PGSEA [60]

1.38.0
1.03
1.46.0
3.18
1.52.0

Table 5.3: List of R Libraries Used
Notes
rmvn used to generate multivariate normal gene expression data
mvGST gene set test [12]
GlobalTest gene set test [11]
ROAST gene set tests (mean, msq, mean50, floormean) [8]
CAMERA gene set test [9]
ROMER gene set tests (mean, floormean, mean50) [10]
GSEAlmperm gene set test [7]
GSA gene set tests (maxmean, mean, absmean) [17]
sigPathway gene set tests (NTk and NEk) [14]
SAFE gene set tests (permutation, bootstrap.t and bootstrap.q) [15]
PAGE gene set test [16]

seen in the Initial Version plot in Fig. 5.1. When testing with p = 10, 000 genes, each test
run was taking an average of 37.89 minutes on the CHPC cluster. This was not practical
given the number of tests we were planning on running.
After profiling the code, it was determined that approximately 97.5% of the CPU
time was spent generating the data while only about 2.5% of the CPU time was spent
performing the actual gene set tests. In order to generate gene expression data with intergene correlation within gene sets, the data generation process was creating a single p × p
covariance matrix Σ that was being passed to the R function mvrnorm from the MASS
library [61]. To increase performance, a number of optimizations were considered, and two
were implemented.
The biggest gain in performance was found by replacing the single large covariance
matrix with a covariance matrix for each gene set. If there are p total genes divided into
k gene sets containing m genes each, there was originally a p × p covariance matrix Σ
that was being passed to the mvrnorm function to generate the gene expression data for
each of the sample groups. When p was large (10,000), the resulting covariance matrix
was found to consume hundreds of megabytes of memory. The original covariance matrix
was a block diagonal matrix containing k matrices of size m × m. The matrices in the
diagonal contained the genewise variance for the gene set and any inter-gene correlation.
The majority of the covariance matrix contained the value 0 and had no effect on the
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resulting data. The optimization made was to replace Σ with a covariance matrix for each
gene set, Σk , call mvrnorm in a loop for each gene set, and append the generated data to
the final data set. This resulted in a dramatic reduction in computation time. For p = 1000,
the data generation process was more than 150 times faster than before. As p increased,
the performance gain was even bigger. For p >= 2500, the data generation process was
over 1000 times faster.
The second performance optimization came from using rmvn (from mvnfast library
version 0.2.5) [53] instead of mvrnorm (from MASS library version 7.3.49) [61] to generate
the multivariate normal data. The performance gain was more even across different values
of p. On average, rmvn generated data approximately 2.3 times faster than mvrnorm.
In the original version, the average time for each run of the simulation framework
increased exponentially in the number of genes p, while in the optimized version, the average
run time increased linearly with p as seen in Fig. 5.1. For tests with 10,000 genes, the
optimized version took about 0.90 minutes per test run compared to 37.89 minutes per run
originally.

Fig. 5.1: Performance Comparison of Original Version and Optimized Version
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Chapter 6
Simulation Results
6.1

Overview
In addition to estimating the power and FDR of each gene set test method as a biolog-

ical parameter of interest was varied over realistic and relevant values, we explored possible
interactions between parameters of interest by combining parameters and running a set of
simulations for each combination of parameter values. Each parameter pairing is summarized with lattice plots for power and FDR for each method, lattice plots for power and
FDR for each method type, and a discussion of the results.
We devised 5 interesting pairings of our parameters of interest: total number of genes
(p) with sample size (n), sample size with proportion DE (πd ), sample size with foldchange (µd ), sample size with inter-gene correlation (r), and proportion DE with inter-gene
correlation.
For each pair of parameters, 100 unique data sets were generated (50 when n = 25 and
n = 50) and tested with each gene set method and the power and FDR were recorded for
each method. In total, 100 test scenarios were tested, 8,700 data sets were generated, and
165,300 gene set tests were performed. The test scenarios consumed a total of 313.04122
CPU hours on the CHPC for an average runtime of 3.1304 hours per scenario.
Many of the methods tested (mvGST, ROAST, ROMER, GSA, SAFE, and sigPathway)
have multiple test statistics or algorithm that can be used that generate different results.
We considered each of these variations its own gene set test method. Including all of these
variations, we tested 19 different gene set test methods from the 10 main gene set test
platforms. In order be able to visualize and interpret the results for the various methods,
we separate the results for power and FDR into 2 plots, each showing 9 methods. The
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ROAST: msq and ROAST: floormean performed similarly across test scenarios, so we chose
to omit ROAST: msq from the plots to improve readability.
The following sections describes the results for the 5 chosen parameter pairings. For
each pairing, we discuss trends in power and FDR individually, then compare method
performance where performance is defined as achieving a certain power threshold while
simultaneously controlling the FDR at Q ≤ 0.05. For the discussion, we will consider
P ≥ 80% to be adequate power and P ≥ 90% to be high power. Finally, we consider
performance by hypothesis type (self-contained and competitive) and by p-value technique
(resampling, rotation, parametric, p-value combination).

6.2

Number Of Genes with Sample Size
This test pairing was performed by combining each value of total number of genes,

p ∈ {2000, 4000, 6000, 8000, 10000}, with each value of sample size, n ∈ {2, 4, 6, 8, 10, 25, 50},
for a total of 35 test scenarios. These scenarios were run with no inter-gene correlation, and
gene sets of size 40 where all 40 of the genes in the test gene set are differentially expressed
by a fold-change value of either 1.5 for power test or 0 for type I error test. The purpose
of this test pair was to see how sample size affects power, how total number of genes affect
power, and if there is any interaction effect between sample size and total number of genes
on power.

6.2.1

Power

The power of each method given each combination of total number of genes and sample
size can be seen in the lattice plots in Fig. 6.1 and Fig. 6.2. The number of samples appears
on the x-axis and the number of genes appears in the vertical groups (rows).
Only the GSEAlm method appears to be greatly affected by the total number of genes,
p. As p increases, the power of GSEAlm decreases. This is due to its relatively high p-values
which do not hold up very well to the multiple hypothesis adjustment. The GSA absolute
mean method (GSA.AM) appears to have been mildly affected by number of genes, with
perhaps a slight drop in power for higher p. The number of genes appears to have little
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effect on the power for the remaining methods with the plots looking approximately the
same going from bottom to top.
The sample size, however, appears to have a dramatic effect on power for many of
the methods. For n = 2, GSA maxmean (GSA.MM), GSA mean (GSA.M), mvGST, and
PAGE had surprisingly high power, while the other methods had low power as expected.
By increasing to n = 4 samples, the power increased substantially for all methods across all
total gene sizes except for all 3 GSA methods and GSEAlm which somehow dropped. After
increasing to n = 6 samples, all of the methods except GSEAlm had reasonable power.

Fig. 6.1: Method Power by Total Number of Genes and Sample Size (1 of 2)
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Fig. 6.2: Method Power by Total Number of Genes and Sample Size (2 of 2)
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6.2.2

FDR

The FDR of each method given each combination of total number of genes, p, and
sample size, n, can be seen in the lattice plots in Fig. 6.3 and Fig. 6.4. A reference line
has been added at our α = 0.05. For FDR, the number of genes, p, appears to have a mild
effect on a few methods with generally slightly higher FDR for higher p. This effect was
compounded somewhat for smaller sample sizes.
Only CAMERA and the 2 mvGST methods correctly controlled the FDR at ≤ 0.05
across all sample sizes and gene set sizes. The ROAST and ROMER methods also performed
well. They controlled FDR for most scenarios and were only slightly above when they did
not control it. This deviation could be attributed to random chance. Most of the other
methods had fairly high FDR for small n which then decreased as n increased. For these
methods, the FDR was more or less controlled at 0.05 by n = 6 or n = 8 samples. For
large p, the SAFE bootstrap methods both appear to need about 50 samples to control the
FDR. For the permutation-based SAFE method, the FDR appears to shoot up dramatically
at n = 4, then drop quite slowly after that indicating that many more samples might be
needed to control the FDR. Curiously, the PAGE methods started with FDR ≤ .05 for
n = 2 which then actually increased as n increased.

6.2.3

Performance

To compare performance of the various methods, we consider power and FDR together.
Table 6.1 ranks the methods according to the number of samples needed to high adequate
power while controlling the FDR across all gene set sizes. The mvGST method performed
the best followed closely by CAMERA and the 3 ROAST methods. These 5 methods were
the only ones that uniformly controlled FDR at ≤ 0.05 while also having high power at
small sample sizes. Of these methods, mvGST had good power at n = 2 and the others at
n = 4. The ROMER methods and GlobalTest controlled FDR at n ≥ 4 and had satisfactory
power somewhere around 4 ≤ n ≤ 6. At n ≥ 6 samples, mvGST Hartung, GSA maxmean,
GSA mean, and sigPathway NEk also performed well. It is worth noting that the FDR of
sigPathway NEk appeared to become uncontrolled with larger samples. At n ≥ 10, GSA
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Fig. 6.3: Method FDR by Total Number of Genes and Sample Size (1 of 2)
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Fig. 6.4: Method FDR by Total Number of Genes and Sample Size (2 of 2)
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absolute mean and sigPathway NTk performed well.
Table 6.1: Samples to Achieve 90% Power and Control FDR at .05 by Method When Gene
Set is 100% DE
Gene Set Test Method Sample Size Needed
mvGST
2
CAMERA
4
ROAST: mean
4
ROAST: msq
4
ROAST: floormean
4
ROMER: mean
4
ROMER: floormean
4
mvGST: Hartung
4
GlobalTest
4 to 6
sigPathway: NEk
6
GSA: maxmean
6
GSA: mean
8
GSA: absmean
8
sigPathway: NTk
≈ 25
SAFE: bootstrap.t
≈ 50
SAFE: bootstrap.q
≈ 50
SAFE: permutation
 50
PAGE
GSEAlm
Recall from Section 3.2.1 and Fig. 3.1 that many real experiments use sample sizes of
n = 2 or n = 3. For these typically used sample sizes, most methods will either fail to
achieve adequate power, have a very high FDR, or both. That is assuming 100% of the
genes in the gene set are differentially expressed as was done in this test. With fewer DE
genes, the power will be even lower. In other words, many experiments currently being
done with small sample sizes may be finding many false positives while failing to find true
positives. The results of this test pairing suggest that at least n = 6 samples should be the
absolute minimum used in practice.

6.2.4

Performance by Hypothesis Type and P-value Technique

The average power and FDR of each hypothesis type and p-value technique is shown
in Fig. 6.5 and Fig. 6.6. It appears that self-contained null hypothesis methods outperform
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competitive null hypothesis methods in both power and FDR. Both types had poor power
at n = 2, but self-contained methods generally had more power at n ≥ 4 for any p. They
also had lower FDR for all n and all p.

Fig. 6.5: Method Type Power by Total Number of Genes and Sample Size
For p-value technique, the p-value combination methods performed best overall with
proper FDR control across scenarios and high power. The rotation based methods also
performed well with FDR control and good power for n ≥ 4. The resampling methods and
parametric methods may have had slightly more power, but much higher FDR. The resampling methods appear to be improving with more samples while the parametric inexplicably
appear to be getting worse with more samples.
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Fig. 6.6: Method Type FDR by Total Number of Genes and Sample Size
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6.3

Sample Size with Proportion DE
Next, we consider a perhaps more realistic case where less than 100% of the genes in

the test gene set are differentially expressed. We estimate how many samples would be
needed by each method to achieve a desirable power while controlling FDR for different
proportions of differentially expressed genes.
In this test pairing, we hold the total number of genes at 4000, the gene set size at
40, the inter-gene correlation at 0, the fold-change at 1.5, and vary the sample size and
the proportion of the test gene set that is differentially expressed. Here, we test each
value of sample size, n ∈ {2, 4, 6, 8, 10, 25, 50}, with each value of proportion DE, πd ∈
{0.25, 0.50, 0.75, 1}. There were a total of 28 test scenarios.

6.3.1

Power

The power of each method as a function of the sample size and the proportion of gene
set that is differentially expressed is shown in the lattice plots in Fig. 6.7 and Fig. 6.8. As
expected, power is low for most methods when the sample size is small or the proportion
of genes differentially expressed is low. In general, the power of each method increases as
either sample size increases or as the proportion of DE genes increases. There is also a
definite interaction between these 2 parameters. As the proportion of genes in the gene set
that are differentially expressed decreases, the methods require more samples to detect a
significant difference.
When 25% of the genes are DE, only GSA mean (GSA.M) and GSA maxmean (GSA.MM)
had decent power to detect significance at small sample sizes. As the sample size increases to
8 or 10, power dramatically improves for a number of methods, specifically mvGST, PAGE,
ROAST mean, ROAST floormean, both variations of sigPathway, SAFE bootstrap.q, and
SAFE bootstrap.t. To achieve desirable power, CAMERA, GlobalTest, and mvGST Hartung appear to need even between 10 and 25 samples. SAFE and both ROMER variations
appear to need many more samples.
When 50% of the genes were DE, the power of a number of methods increases quite a
bit. Specifically, mvGST, GSA maxmean, SAFE bootstrap.q, and sigPathway NEk appear
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Fig. 6.7: Method Power by Proportion Differentially Expressed and Sample Size (1 of 2)
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Fig. 6.8: Method Power by Proportion Differentially Expressed and Sample Size (2 of 2)
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to achieve high power with a sample size of 2; mvGST Hartung, PAGE, SAFE, sigPathway NTk, and SAFE bootstrap.t by sample size of 4; CAMERA, ROAST mean, ROAST
floormean, and ROAST msq by 6; GlobalTest, ROMER mean, and ROMER floormean,
GSA absolute mean by 8 or 10. When most or all of the genes are DE, most methods
appear to do fairly well with 4 or 6 samples.

6.3.2

FDR

The FDR rates for the various methods are shown in Fig. 6.9 and Fig. 6.10. In this test
setup, the mvGST methods and CAMERA and all 3 ROAST methods more or less control
the FDR at ≤ 0.05 for all combinations of sample size and proportion DE. The ROMER
methods also performed well. For a number of methods, the FDR is quite high for small
sample sizes, n ≤ 4 and decreases as n increases with some methods controlling FDR by
n = 6 and most by n = 10. SAFE appears to need a much larger n to control the FDR.
The FDR for PAGE actually appears to increase as n increases.

6.3.3

Performance

Next we consider method performance in terms of power and FDR together. When 50%
of the gene set is DE, mvGST outperformed all other methods, requiring only 2 samples to
achieve good power and control FDR. A handful of other methods perform well with either
4 or 6 samples.
Table 6.2 ranks the methods according to the number of samples needed to achieve
adequate power while controlling the FDR in the case where 25% of the gene set is DE.
ROAST floormean, GSA maxmean (GSA.MM), and sigPathway: NEk performed the best,
requiring 6 samples. As before, the FDR of sigPathway NEk appeared to become uncontrolled with larger samples. The mvGST method, the SAFE bootstrap methods, and the
other 2 GSA methods also performed well at 8 samples.
Since knowing a priori what proportion of the gene sets will be differentially expressed is
impossible, it would be best to plan for lower proportions of DE. Therefore, it would appear
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Fig. 6.9: Method FDR by Proportion Differentially Expressed and Sample Size (1 of 2)
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Fig. 6.10: Method FDR by Proportion Differentially Expressed and Sample Size (2 of 2)
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Table 6.2: Samples to Achieve 90% Power and Control FDR at .05 by Method When Gene
Set is 25% DE
Gene Set Test Method Sample Size Needed
ROAST: floormean
6
GSA: maxmean
6
sigPathway: NEk
6
mvGST
8
GSA: mean
8
GSA: absmean
8
SAFE: bootstrap.t
8
SAFE: bootstrap.q
8
sigPathway: NTk
10
ROAST: mean
10
GlobalTest
10
CAMERA
10
ROMER: mean
 50
ROMER: floormean
 50
SAFE: permutation
 50
PAGE
GSEAlm
that using at least n = 8 to n = 10 samples per group or even more would be advisable in
most conditions to achieve adequate power and control FDR for most methods.

6.3.4

Performance by Type and Technique

The average power and FDR of each type and technique is shown in Fig. 6.11 and
Fig. 6.12. Self-contained methods had lower FDR than competitive methods across all
scenarios and better power for n ≥ 4. When the proportion of DE genes is very low and
n = 2, competitive methods had marginally more power than self-contained methods.
Of the 4 techniques, p-value combination techniques had the lowest FDR across scenarios and high power. For n ≥ 6, these methods are the clear winner. The rotation-based
methods also controlled FDR and appear to have had higher power for n = 4. The resampling methods and parametric methods had similar power profiles to the combination
techniques, but both had much higher FDR. As before, FDR decreased with n for resampling methods and increased for parametric methods with n.
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Fig. 6.11: Method Type Power by Sample Size and Proportion DE
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Fig. 6.12: Method Type FDR by Sample Size and Proportion DE
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6.4

Sample Size with Fold-Change
In prior research, a fold-change difference of 1.3 [38, 39] or 1.5 [40–42] have both been

considered biologically relevant. In this test pairing, we hold the number of genes at 4000,
the size of gene sets at 40, the inter-gene correlation at 0, the proportion of genes in the gene
set that are differentially expressed at .5, and vary the sample size, n ∈ {2, 4, 6, 8, 10, 25, 50},
with fold-change, µd ∈ {1.3, 1.5, 1.7}, for a total of 21 test scenarios.

6.4.1

Power

As expected, we see in Fig. 6.13 and Fig. 6.14 that more samples are needed to detect
smaller fold-change differences in expression. There is quite a bit of variability between the
methods here.

Fig. 6.13: Method Power by Fold-Change and Sample Size (1 of 2)
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Fig. 6.14: Method Power by Fold-Change and Sample Size (2 of 2)
For fold-change of 1.3, the GSA maxmean and GSA mean methods detected significance
fairly well with just 2 samples; mvGST and sigPathway NTk with 4 samples; SAFE, ROAST
floormean, ROAST msq, and sigPathway NTk with 6 samples; mvGST Hartung, CAMERA,
ROAST mean and PAGE with 8 samples; and GlobalTest and both ROMER methods
appear to need somewhere between 10 and 25 samples.
As the fold-change amount is increased, fewer samples are needed for adequate power
for each method. At the 1.5 fold-change difference traditionally considered as biologically
relevant, several of the methods had good power with 4 samples. Other methods required 6
or 8 samples, or in the case of GlobalTest, perhaps slightly more than 10 samples to achieve
adequate power.
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At the larger 1.7 fold-change difference, most methods still do a poor job of finding
significance when the sample size is small. By about 6 samples, most of the methods perform
well.

6.4.2

FDR

As with the other test pairings, the FDR is quite high for some methods for small
sample sizes (see Fig. 6.15 and Fig. 6.16). Most notably, the GSA methods, GSEAlm,
SAFE bootstrap.q, sigPathway NEk, and, to a lesser extent GlobalTest, have very high
FDR when the sample size n < 6, but become controlled around n = 6. The GlobalTest
actually then fails to control FDR as n increases further.

Fig. 6.15: Method FDR by Fold-Change and Sample Size (1 of 2)
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Fig. 6.16: Method FDR by Fold-Change and Sample Size (2 of 2)
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6.4.3

Performance

The method performance comparison for a fold-change of 1.3 is shown in Table 6.3.
Here, mvGST is the clear winner requiring just 4 samples to perform well. A handful of
other methods perform well with 6 or 8 samples.
Table 6.3: Samples to Achieve 90% Power and Control FDR at .05 by Method for FoldChange of 1.3
Gene Set Test Method Sample Size Needed
mvGST
4
ROAST: msq
6
ROAST: floormean
6
GSA: maxmean
6
sigPathway: NEk
6
mvGST: Hartung
6
SAFE: bootstrap.t
8
ROAST: mean
8
GSA: absmean
8
CAMERA
8
SAFE: bootstrap.q
10
GSA: mean
10
ROMER: mean
10 to 25
ROMER: floormean
10 to 25
sigPathway: NTk
≈ 25
GlobalTest
≈ 25
SAFE: permutation
 50
PAGE
GSEAlm
-

6.4.4

Performance by Type and Technique

The average power and FDR of each type and technique is shown in Fig. 6.17 and
Fig. 6.18. To detect various fold-change differences, self-contained and competitive methods
had similar power trends. Competitive methods had slightly higher power to detect a foldchange difference of 1.3 for n = 4, but self-contained methods had more power for n = 6.
Both methods were similar with larger n. With higher fold-change differences, the selfcontained methods had higher power for all n. Self-contained methods also had much lower
FDR than competitive methods for all n.
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Fig. 6.17: Method Type Power by Sample Size and Fold-Change
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Fig. 6.18: Method Type FDR by Sample Size and Fold-Change
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The p-value combination methods performed the best of the method types with the
lowest FDR and generally the highest power across scenarios. The rotation-based methods
had slightly higher FDR, but still more or less controlled it, and slightly lower power in
general. The resampling methods and parametric methods had adequate power, except for
small samples, but failed to control the FDR. Once again, as n increased, the FDR for
resampling methods decreased, but parametric methods increased.

6.5

Sample Size with Inter-Gene Correlation
In this test pairing, we consider how inter-gene correlation affects power and FDR for

different sample sizes. Here, we hold the number of genes at 4000, the size of gene sets at
40, the proportion of genes in the gene set that are differentially expressed at 1, and vary
the sample size, n ∈ {2, 4, 6, 8, 10, 25, 50}, with inter-gene correlation, r ∈ {0, 0.1, 0.2, 0.3},
for a total of 28 test scenarios.

6.5.1

Power

The power plots in Fig. 6.19 and Fig. 6.20 show the power for each method as a function
of inter-gene correlation (x-axis) and sample size (rows). The general trend for most of the
methods is that as inter-gene correlation increases, power decreases. This is because the
effective sample size is decreased with correlated data.
For smaller sample sizes (n ≤ 4), the effect is quite pronounced for a number of methods.
As the sample size increases, the inter-gene correlation effect becomes a lot smaller and, in
many cases, appears to flatten out (mvGST Hartung, ROAST methods, ROMER methods,
PAGE). A few of the methods seem to be less affected by inter-gene correlation when finding
true positives. In particular, the correlation appears to have almost no effect on the power
of mvGST and SAFE and very little effect on GSEAlm, both SAFE bootstrap methods,
and both sigPathway methods. The plot suggests that using a sample size n ≥ 10 would
be advisable to mitigate the loss of effective sample size due to inter-gene correlation.
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Fig. 6.19: Method Power by Samples Size and Inter-Gene Correlation (1 of 2)
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Fig. 6.20: Method Power by Samples Size and Inter-Gene Correlation (2 of 2)
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6.5.2

FDR

The FDR plots for this scenario are shown in Fig. 6.21 and Fig. 6.22. The methods
appear to fall into 2 basic groups.

Fig. 6.21: Method FDR by Sample Size and Intergene Correlation (1 of 2)
The first group of methods seems to be primarily unaffected by inter-gene correlation
with flat FDR lines at each sample size. Of these, CAMERA and the 3 ROAST methods
appear to more or less control the FDR at ≤ 0.05 for all sample sizes and several other
methods control FDR for larger sample sizes (all 3 GSA methods and GSEAlm when n ≥ 6,
GlobalTest and sigPathway NTk when n ≥ 10). Curiously, the FDR for the SAFE method
appears to be only mildly affected by the inter-gene correlation, but gets progressively worse
as the sample size increases.
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Fig. 6.22: Method FDR by Samples Size and Intergene Correlation (2 of 2)
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The other group of methods is definitely affected by inter-gene correlation. For these
methods, as the inter-gene correlation increases, the FDR increases, sometimes quite dramatically. This group includes the mvGST methods, both sigPathway methods, and both
SAFE bootstrap methods. The mvGST Hartung method appears to have a downward trend
indicating it might perform well for higher correlation; however, correlation values above
0.4 are unrealistic in real data as previously established in Section 3.2.5.
Increasing the sample size helps mitigate the effect of correlation on FDR for a few
methods, but has no apparent effect on others. As sample size is increased, the FDR
drops across correlation values for both SAFE boot strap methods and the sigPathway
NEk method, but does not seem to have much effect on FDR for the mvGST methods or
sigPathway NTk.

6.5.3

Performance

The method performance comparison across all inter-gene correlation values is shown in
Table 6.4. CAMERA, the GSA methods, the ROAST methods, and the ROMER methods
performed best. All of them required about 8 samples to achieve 90% power and control
the FDR at .05. A handful of methods did not work very well with inter-gene correlation,
mainly due to their inability to control the FDR.

6.5.4

Performance by Type and Technique

The average power and FDR of each type and technique is shown in Fig. 6.23 and
Fig. 6.24.
Overall, self-contained and competitive tests performed similarly with inter-gene correlation. Both types had fairly high power for n ≥ 6 and near perfect power for n ≥ 8. For
smaller sample sizes, competitive tests had slightly more power. Neither type of method
controlled FDR with nearly identical trends.
Regarding method technique, rotation methods performed best. Rotation was the only
technique to control the FDR. These methods achieved good power for n = 6 or n = 8 when
correlation was highest. Parametric methods had similar trends in power and FDR with
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Table 6.4: Samples to Achieve 90% Power and Control FDR at .05 by Method Across
Inter-Gene Correlation
Gene Set Test Method Sample Size Needed
CAMERA
8
ROAST: mean
8
ROAST: msq
8
ROAST: floormean
8
ROMER: mean
8
ROMER: floormean
8
GSA: maxmean
8
GSA: mean
8
GSA: absmean
8
GlobalTest
10
sigPathway: NEk
10
mvGST
mvGST: Hartung
sigPathway: NTk
SAFE: permutation
SAFE: bootstrap.t
SAFE: bootstrap.q
PAGE
GSEAlm
-
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Fig. 6.23: Method Type Power by Sample Size and Inter-Gene Correlation
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Fig. 6.24: Method Type FDR by Sample Size and Inter-Gene Correlation
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perhaps slightly higher power and slightly higher (and uncontrolled) FDR. The resampling
methods and combination methods had good power, but struggled with FDR with increasing
r.

6.6

Proportion DE with Inter-Gene Correlation
In this test pairing, we hold the number of genes at 4000, the size of gene sets at 40,

the sample size n = 6, and test each value of proportion DE, πd ∈ {0.25, 0.5, 0.75, 1} with
each value of inter-gene correlation, r ∈ {0, 0.1, 0.2, 0.3}, for a total of 16 test scenarios to
see if the proportion DE and inter-gene correlation have an interaction effect.

6.6.1

Power

The power plots (Fig. 6.25 and Fig. 6.26) show that for most methods, the power
decreases as inter-gene correlation increases across the various proportion DE, πd , and that
lower values of πd accelerate the negative effect of inter-gene correlation on power.
When 25% of the genes were DE, only sigPathway NTk, mvGST, and SAFE bootstrap.q held power decently well over increasing correlation, although none of them were
exceptional. When 50% of the genes were DE, mvGST, sigPathway NTk, and the SAFE
bootstrap methods all held power rather well over increasing correlation.

6.6.2

FDR

The FDR results for this scenario are shown in Fig. 6.27 and Fig. 6.28. A number of
methods performed quite well here. CAMERA, GlobalTest, all 3 ROAST methods, and
GSEAlm more or less control FDR at ≤ 0.05 across all proportions of DE and correlation.
GSA maxmean and GSA mean perform fairly well when πd ≥ .75. The FDR appears to be
completely independent of the proportion of DE genes.

6.6.3

Performance

None of the methods performed well with low proportion DE and moderate to high
inter-gene correlation. The methods which performed best on power over increasing corre-
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Fig. 6.25: Method Power by Proportion DE and Intergene Correlation (1 of 2)
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Fig. 6.26: Method Power by Proportion DE and Intergene Correlation (2 of 2)

68

Fig. 6.27: Method FDR by Proportion DE and Intergene Correlation (1 of 2)
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Fig. 6.28: Method FDR by Proportion DE and Intergene Correlation (2 of 2)

70
lation (mvGST, sigPathway NTk, and the SAFE bootstrap methods) had the worst FDR
performance while the methods that controlled FDR (CAMERA, GlobalTest, ROAST,
GSA) had low power. There is a definite inverse relationship between power and FDR for
this parameter pairing.

6.6.4

Performance by Type and Technique

The average power and FDR of each type and technique is shown in Fig. 6.29 and
Fig. 6.30.

Fig. 6.29: Method Type Power by Proportion DE and Inter-Gene Correlation
Self-contained methods had slightly more power than competitive methods when the
proportion of DE genes was lower and lower FDR across tests as well. Both types of methods
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Fig. 6.30: Method Type FDR by Proportion DE and Inter-Gene Correlation
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had quite similar performance and trends.
Rotation-based methods and parametric methods had similar performance and trends
for both power and FDR. Rotation methods performed slightly better because they controlled the FDR, while parametric methods did not. Combination methods had the best
power but worst FDR. Resampling methods had the next best power and next worst FDR.
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Chapter 7
Conclusion
7.1

Summary
In general, the total number of genes had only a mild negative effect on power and

FDR across methods. As p was increased, the power for a few methods dropped due to
p-values not surviving the multiple hypothesis correction, and for a few methods the FDR
increased with p. These results are not new or surprising, but confirm the value of filtering
out irrelevant genes or gene sets in certain experiment scenarios.
As has been previously discussed in Section 3.2.1, many real experiments are using
sample sizes of 2 or 3. As we have shown in this work, this is not an adequate sample size
for power or FDR. Any results from such experiments are highly questionable. To account
for real issues in gene expression data such as inter-gene correlation and to find significance
when less than 100% of the gene sets’ genes are differentially expressed, a minimum of 8 to
10 samples per group should be used.
Prior research [9, 43] has shown that inter-gene correlation is prevalent in microarray
data, commonly ranges between 0 and 0.4, and causes problems for gene set test methods.
This work confirmed that inter-gene correlation causes problems for gene set test methods.
Even mild to moderate values of inter-gene correlation reduce the power or inflate the FDR
(and in many cases both) for every method. Some of the methods here performed well on
power and some performed well on FDR, but none performed particularly well considering
both together. This is definitely an area for potential improvement.
Considering the grouped results, self-contained methods outperformed competitive
methods for most scenarios. In a few cases, competitive methods had higher power, but
self-contained methods generally had higher power overall. In terms of FDR control, selfcontained methods were almost strictly better than competitive methods across all scenarios.
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Methods that combine individual gene p-values had high power and low FDR, even
when the sample size was small, the proportion of genes differentially expressed was low,
or when considering a smaller fold-change difference. The only real downside of these
methods was the FDR inflated quite a bit when there was inter-gene correlation. It is worth
noting that the default mvGST approach uses Stouffer’s p-value combination method which
assumes zero correlation. The Hartung extension assumes some non-negative correlation,
which is estimated and accounted for. This explains the improved FDR control by mvGST
Hartung over mvGST in the presence of inter-gene correlation.
The rotation-based methods were a little more conservative and excelled in controlling
the FDR, even when there was inter-gene correlation. They also maintained decent power,
if the combination of sample size and proportion of differentially expressed genes was high
enough. In general, these methods performed well with 6 to 8 samples.
The power for parametric methods followed similar trends as rotation-based methods
across scenarios, but was slightly higher for small sample sizes. The FDR for parametric
methods was moderately higher, and generally uncontrolled.
The resampling methods had adequate power as long as the sample size was 6 or more,
but struggled with FDR across all scenarios.

7.2

Future Work
There are a number of possibilities for future work in gene set testing. Future simulation

studies could use other parameters of interest. One example that was neglected here is gene
set overlap. In this simulation framework, as well as other previous simulation studies, we
required that each gene only belonged to a single gene set. This is not a fair assumption
as a search through the GO annotations shows that it is quite common for a gene to be
a member of multiple gene sets. Investigation into the degree of gene set overlap and
modeling that into the simulation framework might reveal some new insights into method
performance on real data. Another aspect is gene set size. For simplicity and limiting the
total number of scenarios, we limited the gene set size to 40 for all scenarios. It would
be interesting to do a deeper analysis of gene set sizes that are biologically meaningful
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(excluding the large hierarchical container gene sets), and then do simulations modeling the
common sizes. Another interesting parameter could be the variance used when generating
the gene expression data to replicate the fact that the within-group variance can vary among
gene expression platforms and experiments.
A possible improvement to this work would be to have more granularity of test parameter values for sample size, inter-gene correlation, and proportion DE. For example, many
of our results had noticeable jumps in power between sample sizes of 2 and 4 or 4 and 6.
Including sample sizes 3 and 5 may give more insight into the trends, although the overall
conclusions would probably not change.
Another possibility for improvement or exploration is to investigate the parameters of
interest further to better understand their distributions, then model the test scenarios to
emulate the same behavior by having the parameter values come from a distribution based
on a mean and variance instead of a static value. For example, the correlation between
genes is not typically the same for all pairs of genes within a gene set. Assuming the
true distribution of inter-gene correlations follows a normal distribution, the simulation
framework would emulate this behavior. Instead of using a correlation of 0.1 for every pair
of genes in the gene set, the correlation for each pair might come from a normal distribution
with a mean of 0.1 and a standard deviation of .05 instead. The general idea would be to
first sample from many real datasets to identify the distribution patterns and values for
each of the parameters of interest, and mimic them in the simulations.
Finally, there is a genuine need to develop a new gene set test method or alternate
approach that handles inter-gene correlation more effectively. The results of this work
suggest that the ideal method might somehow utilize the power of combining p-values with
the FDR control of rotation-based methods, although other novel approaches may work
as well or better. It may be possible to extend or revise the Hartung approach to better
estimate and account for inter-gene correlation to preserve better control of the FDR.
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Appendix A
Validation of Inter-Gene Correlation
As described in Section 5.7.2, the simulation framework can generate correlated data
for genes within each gene set. It does this by first generating a correlation matrix, R,
with 1s on the diagonal and the inter-gene correlation coefficient, r, on the off-diagonal. It
then constructs another matrix, D, which is a diagonal matrix of the genewise standard
deviations, σ. Finally, the covariance matrix is the result of the matrix multiplication
Σ = D × R × D.
To validate this method of generating correlated data, we used a feature of the CAMERA method [9] that estimates and returns a vector of inter-gene correlations for each gene
set [45]. For each r ∈ {0, 0.1, 0.2, 0.3, 0.4, 0.5, 0.6, 0.7, 0.8, 0.9}, we generated 250 gene sets
of size 40 for 12 samples with our framework, ran the CAMERA method, and recorded the
CAMERA estimate for r.
The distribution of CAMERA correlation estimates for the 250 gene sets at each r is
shown in Fig. A.1. For each r, the median r estimated by CAMERA is approximately the
same as the r we used to generate the data and the upward trend also follows as expected.
The variance in each boxplot can be explained by the fact that there is randomness in the
actual gene expression data as it is being sampled from M V N (0, Σ). The evidence here
strongly suggests that the framework is correctly generating correlated gene expression data.
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Fig. A.1: CAMERA Inter-Gene Correlation vs Framework Inter-Gene Correlation
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Appendix B
R Code

B.1

Typical Experiment Size

library(ggplot2)
# semi-random exploration of typical gene expression experiments
# random samples of experimental data from the
# Gene Expression Omnibus at NCBI (GEO)
samplesPerGroup =
c(7,6,6,4,4,3,3,3,3,4.5,3,2,2,2,2,2,6,3,3,5,3,3,4,3.5,3,3,3,3,6,5,
5,10,3,10,4,3,3,3,5,4,3,3,4,3,6,3,3,2,3,2,18,23,20,2,3,3,3,9,6,3)
length(samplesPerGroup)
# summarize the sample size variable
summary(samplesPerGroup)
mean(samplesPerGroup)
sd(samplesPerGroup)

# what proportion of the datasets had <= 6 samplesPerGroup
length(samplesPerGroup[samplesPerGroup <= 6])/length(samplesPerGroup)
# what proportion of the datasets had <= 10 samplesPerGroup
length(samplesPerGroup[samplesPerGroup <= 10])/length(samplesPerGroup)
# generate a histrogram of distribution of sample sizes
qplot(samplesPerGroup,
geom = "histogram",
binwidth = 1,
fill = I("black"),
col = I("black"),
alpha = I(.4),
xlim = c(0, 25),
xlab = "Number of Samples Per Group",
ylab = "Count")
B.2

Typical Gene Set Size
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library(AnnotationDbi)
library(GO.db)
library(org.Hs.eg.db)
library(ggplot2)

# for every GO ID, get the gene set size
geneSetLengths = vector(mode="numeric", length = 0)
xx1 <- as.list(org.Hs.egGO2ALLEGS)
length(xx1)
# if this gene set is a Biological Process (BP),
# add its length to the list of gene set lengths
start_time <- Sys.time()
for(i in 1:length(xx1))
{
# GO:0008150 is the BP root - is this GO ID a descendant (IOW a BP)?
if(is.element(names(xx1[i]), GOBPOFFSPRING$"GO:0008150"))
{
geneSetLengths = c(geneSetLengths, length(xx1[[i]]) )
}
}
Sys.time() - start_time
# get some summary statistics
length(geneSetLengths)
summary(geneSetLengths)
mean(geneSetLengths)
sd(geneSetLengths)
# determine how many genesets
length(geneSetLengths[geneSetLengths
length(geneSetLengths[geneSetLengths
length(geneSetLengths[geneSetLengths
length(geneSetLengths[geneSetLengths
length(geneSetLengths[geneSetLengths
length(geneSetLengths[geneSetLengths
length(geneSetLengths[geneSetLengths
length(geneSetLengths[geneSetLengths

<
<
<
<
<
<
<
<

50])/length(geneSetLengths)
75])/length(geneSetLengths)
100])/length(geneSetLengths)
125])/length(geneSetLengths)
150])/length(geneSetLengths)
175])/length(geneSetLengths)
200])/length(geneSetLengths)
47])/length(geneSetLengths)

# generate cumulative density for number of genes 1 to 2000
numGenesInSet = vector(mode="numeric", length = 0)
percentGeneSets = vector(mode="numeric", length = 0)
for(i in 1:2000)
{
numGenesInSet = c(numGenesInSet, i)
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percentGeneSets = c(percentGeneSets,
length(geneSetLengths[geneSetLengths < i])/length(geneSetLengths))
}
# generate a cumulative density plot of the first 50 gene set sizes
qplot(numGenesInSet[1:50], percentGeneSets[1:50],
xlab = "Number of Genes in Gene Set",
ylab = "Gene Sets Containing <= Number of Genes")
B.3

Simulation Framework

# Windows/DEV options
nullDevice = "Nul"
outputFileBase = "c:\\school\\thesis\\output\\sim"
genCSVOutput = FALSE
# for running on the Linux (HPC cluster)
if(Sys.info()[["sysname"]] == "Linux")
{
.libPaths("~/R_libs")
nullDevice = "/dev/null"
outputFileBase = "~/output/sim"
genCSVOutput = TRUE
}
# load libraries
library(mvnfast)
library(limma)
library(mvGST)
library(GSEAlm)
library(GSA)
library(sigPathway)
library(safe)
library(PGSEA)
library(globaltest)

# clear output log
cat("\014")
set.seed(441)
# STEP 1: INITIAL SETUP
# STEP 1A: SETUP DEFAULT VARIABLES FOR TESTS
# s0^2 = prior variance
# d0 = prior degrees of freedom
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# p = total number of genes
# p0 = number genes per gene set
# n1 = number samples in reference group
# n2 = number samples in treatment group
# foldChange = the difference to be added to group 2, set 1 genes
# pUp - proportion of genes in the DE set to be
#
up-regulated in group 2 (0 to 1)
# pDown - proportion of genes in the DE set to be
#
down-regulated in group 2
# intergeneCorr - the intergene correlation coefficient (0 to 1)
# alpha - the value to use when testing significance (0 to 1)
# numRuns = number of simulations to run
# numPerms = number of permutations/rotations to use
#
for permutation/rotation methods
s0 = .25
d0 = 4
p = 4000
p0 = 40
n1 = 6
n2 = 6
foldChange = 1.5
pUp = 1
pDown = 0
intergeneCorr = 0
alpha = 0.05
numRuns = 100
numPerms = 1000
runAll = FALSE
verboseOutput = TRUE

# STEP 1B - process optional command line to override default parameters
# the order is: numRuns p p0 n foldChange pUp intergeneCorr
args <- commandArgs(trailingOnly = TRUE)
if(length(args) > 0)
numRuns = strtoi(args[1], base = 10)
if(length(args) > 1)
p = strtoi(args[2], base = 10)
if(length(args) > 2)
p0 = strtoi(args[3], base = 10)
if(length(args) > 3)
n1 = n2 = strtoi(args[4], base = 10)
if(length(args) > 4)
foldChange = as.numeric(args[5])
if(length(args) > 5)
pUp = as.numeric(args[6])
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if(length(args) > 6)
intergeneCorr = as.numeric(args[7])
if(length(args) > 7)
alpha = as.numeric(args[8])

# instantiate any computed variables after command line input processed
logFoldChange = log(foldChange, 2)
numSets = p/p0
numRots = numSets * 20

# debug output
paste("Starting Simulation Framework:", Sys.time())
paste("p = ", p, ", p0 = ", p0, ", n1 = ", n1, ", n2 = ", n2, ",
fold-change = ", foldChange, ", prop = ", pUp, ", corr = ",
intergeneCorr, ", alpha = ", alpha, ", numRuns = ", numRuns,
sep = "")

# STEP 1C - create the gene sets
# geneSets is for mvGST, ROAST, CAMERA, GSA, romer
# a list containing the name of each gene set set1, set2, ...
# and each set contains the list of gene names in the set
geneSets = list();
# geneSetsMatrix is for GSEAlm and SAFE
# m x p matrix; m is the number of gene sets and p the number of genes
# each element contains a 1 if gene is in the gene set, 0 otherwise
geneSetsMatrix = matrix(data = 0, nrow = numSets, ncol = p)
# gsList is for sigPathway
# a list of lists where each list contains a src, title, and probes
# (the names of genes in the gene set)
gsList = list()
# smcList is for PAGE
smcList = list()
# now actually generate the various gene set structures
for(i in 1:numSets)
{
startGene = ((i-1)*p0 + 1)
endGene = startGene + p0 - 1
index <- startGene:endGene;
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# add this gene set to the geneSets list
geneSets[[paste(’set’, i, sep = "")]] = index
# add this gene set to the geneSetsMatrix
geneSetsMatrix[i,startGene:endGene] = 1
# add this gene set to the gsList
gsListItem = list()
gsListItem$src = toString(i)
gsListItem$title = paste("set",i)
gsListItem$probes = sapply(startGene:endGene, toString)
gsList[[i]] = gsListItem
# add this gene set to the smcList
smcList[[i]] = new("smc", ids = startGene:endGene,
reference = paste("simple smc",i))
}
# add gene set names to avoid annoying warning from SAFE
rownames(geneSetsMatrix) = paste("set", 1:numSets)
# convert gsList to the real gslist for sigPathway
gsList <- selectGeneSets(gsList, sapply(1:p, toString), 10, 1000)

# create roundUp function to round UP on all .5!
roundUp = function(x) trunc(x+0.5);

# function to convert 2 sided pvalues to 1 sided pvalues
p2.p1 <- function(p,diff)
{
p1 <- rep(NA,length(p))
t <- diff >=0
p1[t] <- p[t]/2
p1[!t] <- 1-p[!t]/2
return(p1)
}

# function to perform a multiple hypothesis adjustment
# to a vector of one-sided pvalues
p.adjust.onesided <- function (pvals, method = "BH")
{
two.sided <- convertPvalues(pvals, two.sided = FALSE)
two.adjusted <- p.adjust(two.sided, method = method)
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relative <- ifelse(pvals < 0.5, 1, -1)
one.adjusted <- convertPvalues(two.adjusted, relative)
return(one.adjusted)
}
# function to get the fdr of a set of gene set p-values
get.fdr <- function(p,alpha)
{
denom = sum(p <= alpha)
if(denom == 0)
return(0)
else
return(sum(p[2:length(p)] <= alpha) / denom)
}
# wrapper function for mvGST methods
mvGST <- function(y, design, geneSets, corrAdjust)
{
# fit a linear model and get 1 sided pvalues for each gene
fit <- lmFit(y,design)
fit <- eBayes(fit)
fullTable = topTable(fit, coef = 2, sort = "none", n = Inf)
pvals = p2.p1(fullTable$P.Value, fullTable[,1])
gn <- rownames(fullTable)
names(pvals) <- gn
pvals = cbind(pvals)
# combine gene set pvalues with mvGST profileTable
test <- profileTable(pvals,
organism = "hsapiens",
list.groups = geneSets,
corr.adj = corrAdjust)
# return the BY adjusted p-values
return(test$adjusted.group.pvals)
}

# wrapper function for GlobalTest method
GlobalTest <- function(y, design, numSets, p0)
{
cf = as.factor(design[,2])
pvalues = c()
for(i in 1:numSets)
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{
startGene = ((i-1)*p0 + 1)
endGene = startGene + p0 - 1
# need samples in rows and genes in columns:
mat = t(y[startGene:endGene,])
gt.all = gt(cf ~ mat)
pvalue = gt.all@result[1]
pvalues = c(pvalues, pvalue)
}
# return the BH adjusted p-values
return(p.adjust.onesided(pvalues, "BH"))
}
#
#
#
#
#
#
#
#
#
#
#

RunTest - run a single parameterized test run
simulate a data set, test all methods
s0^2 = prior variance
d0 = prior degrees of freedom
p = total number of genes
p0 = number genes per gene set
n1 = number samples in reference group
n2 = number samples in treatment group
pUp = number 0 to 1 representing proportion of genes in
the DE set to generate as up-regulated
pDown = number 0 to 1 representing proportion of genes in
the DE set to generate as down-regulated
# intergeneCorr = number 0 to 1 representing the intergene correlation
# logFoldChange = the log fold change to simulate for DE genes
RunTest <function(s0, d0, p, p0, n1, n2, pUp, pDown, intergeneCorr, logFoldChange)
{
# STEP 2 - DATA GENERATION
# populate group means according to the requested ratio
muGroup1 = rep(0, p0)
muGroup2 = rep(0, p0)
# make the first genes up, down, or both
# according to the requested proportions
numUp = roundUp(pUp * p0);
numDown = roundUp(pDown * p0);
muGroup2[1:numUp] = logFoldChange
if(numDown > 0)
muGroup2[numUp + 1:numDown] = -logFoldChange
# generata data for each gene set
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for(j in 1:numSets)
{
# generate variance for each gene from inverse chi^2
variance = (d0 * s0^2) / rchisq(p0, d0)
# create a covariance matrix
S = matrix(nrow = p0, ncol = p0, data = 0)
if(intergeneCorr == 0)
{
diag(S) = variance
} else
{
# create matrix with standard deviations on diagonal
stdevs = sqrt(variance)
D = diag(stdevs)
# create correlation matrix
R = matrix(nrow = p0, ncol = p0, data=c(rep(intergeneCorr, p0 * p0)))
diag(R) = 1
#print(R)
# create covariance matrix
S = D %*% R %*% D
}
# now generate and append some data
if(j == 1)
{
y = rmvn(n1, muGroup1, S)
y = t(rbind(y, rmvn(n2, muGroup2, S)))
} else
{
y = rbind(y, t(rmvn(n1+n2, muGroup1, S)))
}
}
# create the design matrix to be used by most methods
design <- cbind(Intercept=1,Group2=c(rep(0,n1), rep(1,n2)))
# construct an ExpressionSet object from our generated data
# for the GSEAlm and PAGE methods
eset = ExpressionSet(y,
new("AnnotatedDataFrame",
data = data.frame(design)))
# STEP 3 - GENE SET TESTS
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# call each test and store the results
# create a data frame to hold the results from each method
results = data.frame(row.names = c("test","pvalue", "fdr"));
# GSA and SAFE both print debug messages that clog up the output file
# suppressing that here
sink(nullDevice)
# ROAST - mean
result = mroast(y, geneSets, design, contrast = 2,
set.statistic = "mean", adjust.method = "BH",
nrot = numRots, sort = "none")
results = rbind(results,
data.frame(test = "ROAST.mean",
pvalue = result$FDR[1],
fdr = get.fdr(result$FDR, alpha)))
# ROAST - msq
result = mroast(y, geneSets, design, contrast = 2,
set.statistic = "msq", adjust.method = "BH",
nrot = numRots, sort = "none")
results = rbind(results,
data.frame(test = "ROAST.msq",
pvalue = result$FDR[1],
fdr = get.fdr(result$FDR, alpha)))

# ROAST - mean50
#result = mroast(y, geneSets, design, contrast = 2,
set.statistic = "mean50", adjust.method = "BH",
nrot = numRots, sort = "none")
#results = rbind(results,
data.frame(test = "ROAST.mean50",
pvalue = result$FDR[1],
fdr = get.fdr(result$FDR, alpha)))

# ROAST - floormean
result = mroast(y, geneSets, design, contrast = 2,
set.statistic = "floormean", adjust.method = "BH",
nrot = numRots, sort = "none")
results = rbind(results,
data.frame(test = "ROAST.floormean",
pvalue = result$FDR[1],
fdr = get.fdr(result$FDR, alpha)))
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# CAMERA
result = camera(y, geneSets, design, contrast = 2,
inter.gene.cor = NA, sort = FALSE)
results = rbind(results,
data.frame(test = "CAMERA",
pvalue = result$FDR[1],
fdr = get.fdr(result$FDR, alpha)))

# mvGST - Stouffer
pvalues = mvGST(y, design, geneSets, "none")
results = rbind(results,
data.frame(test = "mvGST",
pvalue = pvalues[1],
fdr = get.fdr(pvalues, alpha)))
# mvGST - Hartung
pvalues = mvGST(y, design, geneSets, "hartung")
results = rbind(results,
data.frame(test = "mvGST.Hartung",
pvalue = pvalues[1],
fdr = get.fdr(pvalues, alpha)))

# GlobalTest
pvalues = GlobalTest(y, design, numSets, p0)
results = rbind(results,
data.frame(test = "GlobalTest",
pvalue = pvalues[1],
fdr = get.fdr(pvalues, alpha)))

# GSEAlm
result = gsealmPerm(eset, formula = ~Group2, mat = geneSetsMatrix,
nperm = numPerms, removeShift = FALSE,
detailed = FALSE)
# FDR adjusted with BH correction
pvalues = as.numeric(p.adjust.onesided(result[,2], "BH"))
results = rbind(results,
data.frame(test = "GSEAlm",
pvalue = pvalues[1],
fdr = get.fdr(pvalues, alpha)))
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# GSA - maxmean
result = GSA(y, design[,2] + 1, geneSets, 1:p, method = "maxmean",
resp.type = "Two class unpaired",
minsize = 1, maxsize = 1000, nperms = numPerms)
# FDR adjusted with BH correction
pvalues = p.adjust.onesided(result$pvalues.hi, "BH")
results = rbind(results,
data.frame(test = "GSA.MM",
pvalue = pvalues[1],
fdr = get.fdr(pvalues, alpha)))

# GSA - mean
result = GSA(y, design[,2] + 1, geneSets, 1:p, method = "mean",
resp.type = "Two class unpaired",
minsize = 1, maxsize = 1000, nperms = numPerms)
# FDR adjusted with BH correction
pvalues = p.adjust.onesided(result$pvalues.hi, "BH")
results = rbind(results,
data.frame(test = "GSA.M",
pvalue = pvalues[1],
fdr = get.fdr(pvalues, alpha)))

# GSA - absmean
result = GSA(y, design[,2] + 1, geneSets, 1:p, method = "absmean",
resp.type = "Two class unpaired",
minsize = 1, maxsize = 1000, nperms = numPerms)
# FDR adjusted with BH correction
pvalues = p.adjust.onesided(result$pvalues.hi, "BH")
results = rbind(results,
data.frame(test = "GSA.AM",
pvalue = pvalues[1],
fdr = get.fdr(pvalues, alpha)))

# romer - mean
result = romer(y, geneSets, design, contrast = 2,
nrot = numRots, set.statistic = "mean")
# FDR adjusted with BH correction
pvalues = as.numeric(p.adjust.onesided(result[,2], "BH"))
results = rbind(results,
data.frame(test = "ROMER.mean",
pvalue = pvalues[1],
fdr = get.fdr(pvalues, alpha)))
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# romer - floormean
result = romer(y, geneSets, design, contrast = 2,
nrot = numRots, set.statistic = "floormean")
# FDR adjusted with BH correction
pvalue = as.numeric(p.adjust.onesided(result[,2], "BH"))
results = rbind(results,
data.frame(test = "ROMER.floormean",
pvalue = pvalues[1],
fdr = get.fdr(pvalues, alpha)))

# romer - mean50
#result = romer(y, geneSets, design, contrast = 2,
nrot = numRots, set.statistic = "mean50")
# FDR adjusted with BH correction
#pvalues = as.numeric(p.adjust.onesided(result[,2], "BH"))
#results = rbind(results,
data.frame(test = "ROMER.mean50",
pvalue = pvalues[1],
fdr = get.fdr(pvalues, alpha)))

# sigPathway - NTk
result = calculate.NTk(y, design[,2], gsList, nsim = numPerms,
ngroups = 2, verbose = FALSE,
alwaysUseRandomPerm = TRUE)
results = rbind(results,
data.frame(test = "sigPathway.NTk",
pvalue = result$q.value[1],
fdr = get.fdr(result$q.value, alpha)))

# sigPathway - NEk
result = calculate.NEk(y, design[,2], gsList, nsim = numPerms,
ngroups = 2, verbose = FALSE,
alwaysUseRandomPerm = TRUE)
results = rbind(results,
data.frame(test = "sigPathway.NEk",
pvalue = result$q.value[1],
fdr = get.fdr(result$q.value, alpha)))

# SAFE - permutation
result = safe(y, design[,2], C.mat = t(geneSetsMatrix),
method = "permutation", error = "FDR.BH",
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print.it = FALSE)
results = rbind(results,
data.frame(test = "SAFE",
pvalue = result@global.pval[[1]],
fdr = get.fdr(result@global.pval, alpha)))

# SAFE - bootstrap.t
result = safe(y, design[,2], C.mat = t(geneSetsMatrix),
method = "bootstrap.t", error = "FDR.BH",
print.it = FALSE)
results = rbind(results,
data.frame(test = "SAFE.BOOT.T",
pvalue = result@global.pval[[1]],
fdr = get.fdr(result@global.pval, alpha)))

# SAFE - bootstrap.q
result = safe(y, design[,2], C.mat = t(geneSetsMatrix),
method = "bootstrap.q", error = "FDR.BH",
print.it = FALSE)
results = rbind(results,
data.frame(test = "SAFE.BOOT.Q",
pvalue = result@global.pval[[1]],
fdr = get.fdr(result@global.pval, alpha)))

# PAGE (PGSEA)
pgNF = PGSEA(eset, smcList, range = c(10, 1000), ref = 1:n1,
p.value = NA, weighted = FALSE, enforceRange = TRUE)
fit = lmFit(pgNF, design)
fit = eBayes(fit)
pvalues = topTable(fit, sort = "none", n = numSets)$adj.P.Val
results = rbind(results,
data.frame(test = "PAGE",
pvalue = pvalues[1],
fdr = get.fdr(pvalues, alpha)))
# restoring debug printing
sink()
#print(results)
return(results);
}
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RepeatTest <- function(s0, d0, p, p0, n1, n2, pUp, pDown, intergeneCorr,
logFoldChange, numRuns, alpha)
{
# NOTE the order of tests here must match the order in RunTest function
# the correct code to look it up by name was too slow on performance
test = c("ROAST.mean", "ROAST.msq", "ROAST.floormean", "CAMERA",
"mvGST", "mvGST.Hartung", "GlobalTest", "GSEAlm", "GSA.MM",
"GSA.M", "GSA.AM", "ROMER.mean", "ROMER.floormean",
"sigPathway.NTk", "sigPathway.NEk", "SAFE", "SAFE.BOOT.T",
"SAFE.BOOT.Q", "PAGE")
numTests = length(test)
power = rep(0, numTests)
fdr = rep(0, numTests)
fullResults = data.frame(test, power, fdr);
for(i in 1:numRuns)
{
# run the simulation and to all tests
results = RunTest(s0, d0, p, p0, n1, n2, pUp, pDown,
intergeneCorr, logFoldChange)
if(verboseOutput == TRUE)
print(paste("Test Run", i, "finished:", date()))
# look at the results and decide if significant or not
for (row in 1:nrow(results))
{
# test against the predefined alpha for significance
if( results[row, "pvalue"] <= alpha)
{
fullResults[row, "power"] = fullResults[row, "power"] + 1
}
# update the fdr rate cumulative
fullResults[row, "fdr"] = fullResults[row, "fdr"] +
results[row, "fdr"]
}
}
# update the significance rate and false discovery rate for each test
fullResults$power = fullResults$power / numRuns
fullResults$fdr = fullResults$fdr / numRuns
# STEP 4 - SUMMARIZE RESULTS
print("Test Scenario finished:", quote = FALSE)
print("s0,
d0,
p,
p0,
n1,
n2,
pUp,
r,
lfc,
runs, alpha", quote = FALSE)

pDn,
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output = c(s0, d0, p, p0, n1, n2, pUp, pDown, intergeneCorr,
logFoldChange, numRuns, alpha)
print(paste(output, collapse = ",
"), quote = FALSE)
print(fullResults)
# write the results to a unique file name
# based on the test scenario parameters
if(genCSVOutput)
write.csv(fullResults,
file = paste(paste(outputFileBase, p, p0, n1, foldChange,
pUp, intergeneCorr, sep = "_"),
"csv", sep = "."))
return(1);
}

# Run the test scenario the specified number of times
startTime = Sys.time()
RepeatTest(s0, d0, p, p0, n1, n2, pUp, pDown, intergeneCorr,
logFoldChange, numRuns, alpha);
endTime = Sys.time()
runTime = difftime(endTime, startTime, units = "mins")
runTime
# add this test run to the runlog table
runTime = as.double(runTime)
if(genCSVOutput)
{
write.table(data.frame(p, p0, n1, n2, pUp, pDown, intergeneCorr,
foldChange, logFoldChange, numRuns,
startTime, endTime, runTime),
"runlog.csv",
col.names = !file.exists("runlog.csv"),
row.names = FALSE,
quote = FALSE,
sep = ",",
append = TRUE)
}
B.4

Simulation Analysis

library(lattice)
library(latticeExtra)
library(gdata)
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# remove the results csv files - they will be regenerated
file.remove("results.csv")
file.remove("results_grouped.csv")

# methodSet = which set of methods to plot
# 1 = plot the main 9 methods for the thesis chapter
# 2 = plot the other 9 methods for the appendix
# 3 = plot by method groupings:
#
competitive, self-contained, resampling, rotation, parametric
for(methodSet in 1:3)
{
# testPairing = which test scenario pairing to summarize:
# 1 = numGenes/numSamples
# 2 = numSamples/proportionDE
# 3 = numSamples/foldChange
# 4 = numSamples/igCorrelation
# 5 = proportionDE/igCorrelation
for(testPairing in 1:5)
{
# filename and directory stuff
if(testPairing == 1) { pairingName = "genes_samples"} else
if(testPairing == 2) { pairingName = "samples_proportion"} else
if(testPairing == 3) { pairingName = "samples_foldchange"} else
if(testPairing == 4) { pairingName = "samples_correlation"} else
if(testPairing == 5) { pairingName = "proportion_correlation"}
directory = paste(pairingName, "/", sep = "")
#
#
#
#
#
#
#
#

the file names look like: sim_a_b_c_d_e_f.csv
where the items are the parameters of interest
a = total number of genes
b = gene set size
c = number of samples per group
d = fold-change value
e = proportion of genes that are DE
f = inter-gene correlation coefficient

# loop through all csv files in the directory and build a
# new data frame with a column of significance rates for
# each test scenario, plus columns a through f above
results = data.frame()
fileNames = dir(directory, pattern =".csv")
for(i in 1:length(fileNames))
{
# read in the file
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result = read.table(paste(directory, fileNames[i], sep = ""),
header=TRUE,
sep = ",",
stringsAsFactors = FALSE)
# parse the file name into the test scenario parameters
parameters = unlist(strsplit(gsub(".csv",
"",
fileNames[i],
fixed = TRUE),
"_"))
# add the columns for the parameters from the test
result["numGenes"] = strtoi(parameters[2], 10)
result["setSize"] = strtoi(parameters[3], 10)
result["numSamples"] = strtoi(parameters[4], 10)
result["foldChange"] = as.numeric(parameters[5])
result["proportionDE"] = as.numeric(parameters[6])
result["interGeneCorrelation"] = as.numeric(parameters[7])
# append this result to the full results
results = rbind(results, result)
}
# cleanup column names/values for plotting
results$X = NULL
colnames(results)[colnames(results) == "test"] <- "method"
results$method[results$method == "camera"] = "CAMERA"
# take a subset of the methods for plotting
csvResultsFile = "results.csv"
if(methodSet == 1) {
results = results[results$method %in% c("mvGST",
"ROAST.mean",
"CAMERA",
"GlobalTest",
"SAFE",
"GSA.MM",
"sigPathway.NTk",
"PAGE",
"ROMER.mean"),]
fileExtension = "_main"
} else if(methodSet == 2) {
results = results[results$method %in% c("mvGST.Hartung",
"ROAST.floormean",
"GSEAlm",
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"GSA.M",
"GSA.AM",
"ROMER.floormean",
"sigPathway.NEk",
"SAFE.BOOT.T",
"SAFE.BOOT.Q"),]
fileExtension = "_appendix"
} else {
# create a new data frame with
# aggregate data for each method type:
# self-contained, competitive,
# rotation, resampling, parametric, combine
# aggregate data for all competitive methods
temp = results[results$method %in% c("CAMERA",
"GSA.MM",
"GSA.M",
"GSA.AM",
"PAGE",
"ROMER.mean",
"ROMER.floormean",
"SAFE",
"SAFE.BOOT.T",
"SAFE.BOOT.Q",
"sigPathway.NTk"),]
dfp = aggregate(power ~ numGenes + setSize + numSamples +
foldChange + proportionDE +
interGeneCorrelation,
FUN = mean, data = temp)
dff = aggregate(fdr ~ numGenes + setSize + numSamples +
foldChange + proportionDE +
interGeneCorrelation,
FUN = mean, data = temp)
results2 = cbind(method = "Competitive", merge(dfp,dff))
# aggregate data for all self-contained methods
temp = results[results$method %in% c("mvGST",
"mvGST.Hartung",
"ROAST.mean",
"ROAST.msq",
"ROAST.floormean",
"GlobalTest",
"sigPathway.NEk"),]
dfp = aggregate(power ~ numGenes + setSize + numSamples +
foldChange + proportionDE +
interGeneCorrelation,
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FUN = mean, data = temp)
dff = aggregate(fdr ~ numGenes + setSize + numSamples +
foldChange + proportionDE +
interGeneCorrelation,
FUN = mean, data = temp)
results2 = rbind(results2,
cbind(method = "Self-Contained", merge(dfp,dff)))
# aggregate data for all resampling methods
temp = results[results$method %in% c("SAFE",
"SAFE.BOOT.T",
"SAFE.BOOT.Q",
"GSA.MM",
"GSA.M",
"GSA.AM",
"sigPathway.NTk",
"sigPathway.NEk"),]
dfp = aggregate(power ~ numGenes + setSize + numSamples +
foldChange + proportionDE +
interGeneCorrelation,
FUN = mean, data = temp)
dff = aggregate(fdr ~ numGenes + setSize + numSamples +
foldChange + proportionDE +
interGeneCorrelation,
FUN = mean, data = temp)
results2 = rbind(results2,
cbind(method = "Resampling", merge(dfp,dff)))
# aggregate data for all rotation methods
temp = results[results$method %in% c("ROAST.mean",
"ROAST.msq",
"ROAST.floormean",
"ROMER.mean",
"ROMER.floormean"),]
dfp = aggregate(power ~ numGenes + setSize + numSamples +
foldChange + proportionDE +
interGeneCorrelation,
FUN = mean, data = temp)
dff = aggregate(fdr ~ numGenes + setSize + numSamples +
foldChange + proportionDE +
interGeneCorrelation,
FUN = mean, data = temp)
results2 = rbind(results2,
cbind(method = "Rotation", merge(dfp,dff)))
# aggregate data for all parametric methods
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temp = results[results$method %in% c("CAMERA",
"GlobalTest",
"PAGE"),]
dfp = aggregate(power ~ numGenes + setSize + numSamples +
foldChange + proportionDE +
interGeneCorrelation,
FUN = mean, data = temp)
dff = aggregate(fdr ~ numGenes + setSize + numSamples +
foldChange + proportionDE +
interGeneCorrelation,
FUN = mean, data = temp)
results2 = rbind(results2,
cbind(method = "Parametric", merge(dfp,dff)))
# aggregate data for all p-value combination methods
temp = results[results$method %in% c("mvGST",
"mvGST.Hartung"),]
dfp = aggregate(power ~ numGenes + setSize + numSamples +
foldChange + proportionDE +
interGeneCorrelation,
FUN = mean, data = temp)
dff = aggregate(fdr ~ numGenes + setSize + numSamples +
foldChange + proportionDE +
interGeneCorrelation,
FUN = mean, data = temp)
results2 = rbind(results2,
cbind(method = "Combination", merge(dfp,dff)))
# copy results2 into the object that will be used for the plots
results = results2
# file name options
csvResultsFile = "results_grouped.csv"
fileExtension = "_grouped"
}
# save the results table to the master file
write.table(results,
csvResultsFile,
col.names = !file.exists(csvResultsFile),
row.names = FALSE,
quote = FALSE,
sep = ",",
append = TRUE)
# build the plot(s) based on the test pairing being run
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if(testPairing == 1)
{
powerPlot = useOuterStrips(xyplot(power~as.factor(numSamples)|
method*as.factor(numGenes),
main = "Method Power by Number of Genes and Sample Size",
xlab = "Number of Samples",
ylab = "Power",
data = results,
type = c("a","p")))
fdrPlot = useOuterStrips(xyplot(fdr~as.factor(numSamples)|
method*as.factor(numGenes),
main = "Method False Discovery Rate
by Number of Genes and Sample Size",
xlab = "Number of Samples",
ylab = "False Discovery Rate",
data = results,
type = c("a","p"),
panel = function(x,y,...){
panel.refline(h = 0.05, col = "darkgrey")
panel.xyplot(x,y,...)}))
} else if (testPairing == 2) {
powerPlot = useOuterStrips(xyplot(power~as.factor(numSamples)|
method*as.factor(proportionDE),
main = "Method Power by Proportion DE and Sample Size",
xlab = "Number of Samples",
ylab = "Power",
data = results,
type = c("a","p")))
fdrPlot = useOuterStrips(xyplot(fdr~as.factor(numSamples)|
method*as.factor(proportionDE),
main = "Method False Discovery Rate
by Proportion DE and Sample Size",
xlab = "Number of Samples",
ylab = "False Discovery Rate",
data = results,
type = c("a","p"),
panel = function(x,y,...){
panel.refline(h = 0.05, col = "darkgrey")
panel.xyplot(x,y,...)}))
} else if (testPairing == 3) {
powerPlot = useOuterStrips(xyplot(power~as.factor(numSamples)|
method*as.factor(foldChange),
main = "Method Power by Fold-Change and Sample Size",
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xlab
ylab
data
type

=
=
=
=

"Number of Samples",
"Power",
results,
c("a","p")))

fdrPlot = useOuterStrips(xyplot(fdr~as.factor(numSamples)|
method*as.factor(foldChange),
main = "Method False Discovery Rate
by Fold-Change and Sample Size",
xlab = "Number of Samples",
ylab = "False Discovery Rate",
data = results,
type = c("a","p"),
panel = function(x,y,...){
panel.refline(h = 0.05, col = "darkgrey")
panel.xyplot(x,y,...)}))
} else if (testPairing == 4) {
powerPlot = useOuterStrips(xyplot(power~
as.factor(interGeneCorrelation)|
method*as.factor(numSamples),
main = "Method Power
by Sample Size and Intergene Correlation",
xlab = "Intergene Correlation",
ylab = "Power",
data = results,
type = c("a","p")))
fdrPlot = useOuterStrips(xyplot(fdr~
as.factor(interGeneCorrelation)|
method*as.factor(numSamples),
main = "Method False Discovery Rate
by Sample Size and Intergene Correlation",
xlab = "Intergene Correlation",
ylab = "False Discovery Rate",
data = results,
type = c("a","p"),
panel = function(x,y,...){
panel.refline(h = 0.05, col = "darkgrey")
panel.xyplot(x,y,...)}))
} else if (testPairing == 5) {
powerPlot = useOuterStrips(xyplot(power~
as.factor(interGeneCorrelation)|
method*as.factor(proportionDE),
main = "Method Power
by Proportion DE and Intergene Correlation",
xlab = "Intergene Correlation",
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ylab = "Power",
data = results,
type = c("a","p")))
fdrPlot = useOuterStrips(xyplot(fdr~
as.factor(interGeneCorrelation)|
method*as.factor(proportionDE),
main = "Method False Discovery Rate
by Proportion DE and Intergene Correlation",
xlab = "Intergene Correlation",
ylab = "False Discovery Rate",
data = results,
type = c("a","p"),
panel = function(x,y,...){
panel.refline(h = 0.05, col = "darkgrey")
panel.xyplot(x,y,...)}))
}
# save the power plot to a file
png(filename = paste("..\\LaTex\\images\\", pairingName,
fileExtension,
".png",
sep = ""),
width = 1200, height = 1085)
plot(powerPlot)
dev.off()
# save the fdr plot to a file
png(filename = paste("..\\LaTex\\images\\",
pairingName,
"_fdr",
fileExtension,
".png",
sep = ""),
width = 1200, height = 1085)
plot(fdrPlot)
dev.off()
}
}

